Selective serotonin reuptake inhibitors

SSRI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AB 1 out of 7 registries used, show all original rules.	121504
4. Check minimum number of events Min. number of events 3	121504
5. Include endpoints None	121504
6. Filter based on genotype QC (FinnGen only)	109179

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SSRI
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AB
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Selective serotonin reuptake inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	109179	74893	34286
Unadjusted period prevalence (%)	23.18	26.59	15.72
Median age at first event (years)	41.35	39.29	45.86

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
67355: Matched controls
350003

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01MA02

ATC

ciprofloxacin; systemic

1.4

323.3

21408

86430

UJF32

NOMESCO Finland

Coloscopy

1.5

323.0

13611

50319

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

5.3

322.5

864

858

IGP01

NOMESCO Finland

Psychiatric family contact

8.5

322.0

590

363

R06.5

ICD-10 Finland

Mouth breathing

1.9

321.9

5003

14159

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

321.6

17019

65882

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

321.5

5589

16411

F50.2

ICD-10 Finland

Bulimia nervosa

15.1

320.6

437

151

G04BD04

ATC

oxybutynin; oral, transdermal

2.4

319.6

2594

5640

Z73.0

ICD-10 Finland

Burn-out

2.6

318.5

2243

4540

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

26.0

317.2

364

N05CD08

ATC

midazolam; nasal, systemic

3.8

316.8

1227

1695

T90

ICPC

Diabetes non-insulin dependent

1.5

316.2

12521

45649

P80

ICPC

Personality disorder

26.2

315.0

361

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

13.1

313.7

455

182

J01CA08

ATC

pivmecillinam; oral

1.4

313.5

21090

85269

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

313.3

12870

47280

J01CA04

ATC

amoxicillin; systemic

1.4

313.2

51348

241290

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

312.9

3327

8163

J01FA06

ATC

roxithromycin; oral

1.4

312.4

21457

87060

F61

ICD-10 Finland

Mixed and other personality disorders

22.4

312.3

373

N17

ICPC

Vertigo/dizziness

1.7

311.9

6792

21336

F21

ICD-10 Finland

Schizotypal disorder

13.5

311.7

446

173

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

311.3

2723

6133

M01AC06

ATC

meloxicam; systemic, rectal

1.4

310.4

18510

73189

M79.1

ICD-10 Finland

Myalgia

1.7

310.2

8107

26764

N07BA03

ATC

varenicline; oral

2.4

309.7

2641

5878

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

309.5

7412

23904

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

308.7

14764

55945

IAA01, ,

SPAT

7.3

308.6

628

450

SPAT1260

SPAT

Consultation of another employee

1.6

308.5

9280

31739

Z01.2

ICD-10 Finland

Dental examination

1.4

308.5

27778

117955

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.1

308.4

721

616

309

Kela drug reimbursment

Nalmefene and naltrexone

25.8

307.7

380

N05BA05

ATC

potassium clorazepate; oral

12.4

307.7

600

254

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

4.1

307.7

1425

1836

Z2446

NOMESCO Finland

Social worker

3.3

307.7

4379

7261

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

39.6

307.7

8241

1227

Z2221

NOMESCO Finland

Medical doctor

1.6

307.7

15226

55447

M79.7

ICD-10 Finland

Fibromyalgia

5.6

307.7

2034

1940

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

14.4

307.7

516

187

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

307.7

25335

97788

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

307.7

6839

20592

N05AF01

ATC

flupentixol; systemic

19.6

307.7

1283

346

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.5

307.7

6005

12955

A02BA02

ATC

ranitidine; systemic

1.9

307.7

10594

30761

AA400

NOMESCO Finland

Electroconvulsive therapy

65.3

307.7

746

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.1

307.7

2064

1549

E0000UV, ,

ATC

1.4

307.7

24365

99017

M54.5

ICD-10 Finland

Low back pain

1.7

307.7

22371

79251

F33.8

ICD-10 Finland

Other recurrent depressive disorders

56.5

307.7

817

N06AX26

ATC

vortioxetine; oral

49.5

307.7

8626

1036

V03AA01, ,

ATC

9.9

307.7

1286

690

F60.9

ICD-10 Finland

Personality disorder, unspecified

24.5

307.7

1153

249

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

13.3

307.7

1892

761

N06AX16

ATC

venlafaxine; oral

41.2

307.7

17187

2884

F51

ICD-10 Finland

Nonorganic sleep disorders

3.1

307.7

2650

4618

N06AB08

ATC

fluvoxamine; oral

44.5

307.7

2953

360

N04AA02

ATC

biperiden; systemic

8.5

307.7

1451

909

N06AB04

ATC

citalopram; systemic

41.5

307.7

33102

7962

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

307.7

15159

52789

T82

ICPC

Obesity

2.7

307.7

2515

4926

ZY010

NOMESCO Finland

Hospital outpatient

5.1

307.7

4203

4527

N02BF01

ATC

gabapentin; oral

2.3

307.7

5727

13841

G44.2

ICD-10 Finland

Tension-type headache

2.0

307.7

8113

22094

N05AE04

ATC

ziprasidone; systemic

24.5

307.7

496

106

N06AG02

ATC

moclobemide; oral

30.4

307.7

4328

790

IER01

NOMESCO Finland

Psychoeducation, group

15.8

307.7

574

190

M25.5

ICD-10 Finland

Pain in joint

1.5

307.7

18261

71227

IGY99, ,

SPAT

4.8

307.7

1552

1698

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.6

307.7

3359

7042

A06AD11

ATC

lactulose; oral

2.4

307.7

8954

21366

Z3226

NOMESCO Finland

Physiotherapist

1.7

307.7

9797

31100

N06AA09

ATC

amitriptyline; systemic

7.0

307.7

6778

5499

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

157.5

307.7

1015

SPAT1234

SPAT

Support of social functional capacity

3.1

307.7

2937

5088

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

307.7

5747

16107

T36

ICD-10 Finland

Poisoning by systemic antibiotics

13.3

307.7

4314

1791

P18

ICPC

Medication abuse

14.2

307.7

498

183

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.1

307.7

7758

8653

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

11.3

307.7

865

403

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

8.3

307.7

10758

7858

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

307.7

11386

37162

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

307.7

11803

41118

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

307.7

5760

14434

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

307.7

4920

11501

F10.20

ICD-10 Finland

Alcohol dependence currently independent

15.2

307.7

1962

689

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

307.7

17433

64381

D11

ICPC

Diarrhoea

1.9

307.7

7265

21129

F10.25

ICD-10 Finland

Alcohol dependence continuous use

10.1

307.7

1488

781

N03AX11

ATC

topiramate; oral

4.9

307.7

1457

1564

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

33502

138295

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

26.4

307.7

738

147

ZY000

NOMESCO Finland

Hospital inpatient

9.2

307.7

982

562

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

307.7

3654

8291

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

307.7

3332

6908

IHZ04, ,

SPAT

8.7

307.7

1456

885

SFA20

NOMESCO Finland

Two-surface restoration

1.4

307.7

35102

152669

SPAT1243

SPAT

Psychiatric/psychological examination

7.6

307.7

2208

1544

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

18910

73644

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

307.7

14502

53357

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

20.3

307.7

558

144

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

19.2

307.7

893

245

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

307.7

13593

48226

ICB06, ,

NOMESCO Finland

16.0

307.7

604

198

K59.0

ICD-10 Finland

Constipation

2.3

307.7

3130

7308

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

5.9

307.7

857

758

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.3

307.7

1428

1198

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

32.8

307.7

1873

305

M03BX02

ATC

tizanidine; oral

1.7

307.7

37834

152620

C07AB07

ATC

bisoprolol; oral

1.6

307.7

27056

104183

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

307.7

22028

88852

P99

ICPC

Psychological disorders other

10.5

307.7

2897

1491

E66.8

ICD-10 Finland

Other obesity

2.7

307.7

3393

6634

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

10.1

307.7

1222

639

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

307.7

10961

34486

F31.8

ICD-10 Finland

Other bipolar affective disorders

23.1

307.7

1778

411

R06.0

ICD-10 Finland

Dyspnoea

1.8

307.7

15911

52021

F10.24

ICD-10 Finland

Alcohol depence active use

12.5

307.7

1331

564

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

47.9

307.7

2907

329

R52.2

ICD-10 Finland

Other chronic pain

3.3

307.7

1983

3234

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

43337

169667

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

16.3

307.7

753

243

J01EA01

ATC

trimethoprim; systemic

1.5

307.7

13555

49037

N05CF02

ATC

zolpidem; oral

4.4

307.7

13792

19519

N06AX12

ATC

bupropion; oral

41.9

307.7

8878

1264

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

58.0

307.7

1378

126

J01DB01

ATC

cefalexin; oral

1.6

307.7

52286

239958

F32.1

ICD-10 Finland

Moderate depressive episode

14.2

307.7

6419

2574

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.5

307.7

1052

736

Z2445

NOMESCO Finland

Psychologist

5.0

307.7

2976

3216

D01

ICPC

Abdominal pain/cramps general

1.8

307.7

7310

22070

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

13.0

307.7

1887

772

A03CA02

ATC

clidinium and psycholeptics; oral

2.9

307.7

3130

5847

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

25735

96805

F50.9

ICD-10 Finland

Eating disorder, unspecified

8.3

307.7

685

433

F32.8

ICD-10 Finland

Other depressive episodes

16.7

307.7

1414

449

P25

ICPC

Phase of life problem adult

3.3

307.7

2840

4558

IEV99

NOMESCO Finland

Other psychiatric network intervention

14.3

307.7

466

171

F33

ICD-10 Finland

Recurrent depressive disorder

46.8

307.7

2418

278

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

307.7

7575

23442

N05CF01

ATC

zopiclone; oral

4.5

307.7

26780

44676

P28

ICPC

Limited function/disability (P)

9.1

307.7

608

350

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

8139

16249

F39

ICD-10 Finland

Unspecified mood [affective] disorder

11.3

307.7

1612

756

KMAK, ,

NOMESCO Finland

1.4

307.7

29549

125845

N05BA12

ATC

alprazolam; oral

10.8

307.7

10582

5920

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

17.6

307.7

897

268

N06BA04

ATC

methylphenidate; oral

6.1

307.7

2866

2544

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

88.8

307.7

2342

142

R74

ICPC

Upper respiratory infection acute

1.5

307.7

19927

78510

N05CD02

ATC

nitrazepam; oral

6.3

307.7

1025

852

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

8271

22901

N06AX11

ATC

mirtazapine; oral

10.7

307.7

34106

30617

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.3

307.7

1297

1296

F41.8

ICD-10 Finland

Other specified anxiety disorders

6.5

307.7

2733

2248

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

16.6

307.7

3282

1076

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

307.7

12894

45655

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

11.3

307.7

641

297

IAB01, ,

SPAT

20.2

307.7

470

122

N05AH02

ATC

clozapine; systemic

10.0

307.7

1578

837

N06AA22, ,

ATC

36.3

307.7

458

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.1

307.7

1468

1535

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

307.7

2977

5746

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

307.7

8299

26323

C07AA05

ATC

propranolol; systemic

3.7

307.7

16550

28080

N05AX15

ATC

cariprazine; oral

27.5

307.7

379

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

307.7

45549

199325

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

62.9

307.7

5366

481

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

6.5

307.7

754

608

N05AA02

ATC

levomepromazine; systemic

14.1

307.7

4042

1583

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

12.7

307.7

542

223

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

12.8

307.7

654

268

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

22.8

307.7

527

121

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.1

307.7

4027

5312

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

307.7

24988

98158

R11

ICD-10 Finland

Nausea and vomiting

2.2

307.7

5192

12920

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

42.9

307.7

337

P74

ICPC

Anxiety disorder/anxiety state

11.5

307.7

4831

2346

N06AX05

ATC

trazodone; oral

52.3

307.7

2267

233

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.2

307.7

629

403

IGY02, ,

SPAT

12.7

307.7

1414

592

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

307.7

6848

20778

N05AD01

ATC

haloperidol; systemic

4.4

307.7

2153

2592

N04BC05

ATC

pramipexole; oral

2.6

307.7

4061

8337

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

307.7

10866

37275

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

68.1

307.7

430

N06AA10

ATC

nortriptyline; systemic

7.4

307.7

1151

818

P58

ICPC

Psychological, Therapeutic counselling/listening

4.4

307.7

1388

1683

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

307.7

20329

75911

F51.0

ICD-10 Finland

Nonorganic insomnia

3.9

307.7

13472

21298

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

307.7

10315

32812

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

307.7

16132

45674

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

307.7

7451

22353

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

14.8

307.7

697

247

J01DA01

ATC

[U] cefalexin

1.5

307.7

36886

158033

N03AX12

ATC

[U] gabapentin; oral

2.6

307.7

9593

20989

IGY02

NOMESCO Finland

Psychiatric monitoring contact

11.2

307.7

3048

1474

SFA10

NOMESCO Finland

One-surface restoration

1.5

307.7

33636

142449

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

307.7

16900

55551

A02BC03

ATC

lansoprazole; oral

1.8

307.7

16403

52526

188

Kela drug reimbursment

Psychosis requiring demanding treatment

11.6

307.7

716

323

R53

ICD-10 Finland

Malaise and fatigue

2.4

307.7

18137

46743

SPAT1254

SPAT

Administration of medicine

1.9

307.7

8545

25484

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

33.4

307.7

453

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

7.6

307.7

869

604

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

14.7

307.7

3064

1134

N05AF03

ATC

chlorprothixene; systemic

19.0

307.7

2572

731

N03AG01

ATC

valproic acid; systemic, rectal

6.5

307.7

5332

4547

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

307.7

2237

4119

N02AA05

ATC

oxycodone; systemic

1.7

307.7

9230

29412

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

27846

111663

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.0

307.7

3377

4503

SPAT1307

SPAT

Psychosocial counselling and guidance

4.4

307.7

5072

6384

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

307.7

10167

32319

A02BC01

ATC

omeprazole; systemic

1.8

307.7

16325

51973

A02BC05

ATC

esomeprazole; systemic

1.8

307.7

24370

85053

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

25.1

307.7

437

Z08

ICPC

Social welfare problem

5.7

307.7

809

742

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

33.8

307.7

804

125

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

7.9

307.7

1010

671

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

7.6

307.7

3341

2378

SPAT1238

SPAT

Brief therapy

5.9

307.7

1179

1056

A01

ICPC

Pain general/multiple sites

2.3

307.7

5817

13963

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

307.7

3508

7383

Z71.8

ICD-10 Finland

Other specified counselling

1.6

307.7

20802

77124

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

17.8

307.7

1490

445

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

45144

197636

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

8.8

307.7

871

519

OAB93, ,

SPAT

2.3

307.7

3931

9130

EBA00

NOMESCO Finland

Extraction of tooth

1.5

307.7

22300

86166

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

307.7

2868

5297

F32

ICD-10 Finland

Depressive episode

17.8

307.7

6197

1981

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

42.7

307.7

2413

304

R01AD09

ATC

mometasone; nasal

1.5

307.7

26785

107874

Z72.1

ICD-10 Finland

Alcohol use

5.9

307.7

880

784

F34.1

ICD-10 Finland

Dysthymia

41.6

307.7

4163

554

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

19.7

307.7

2661

731

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

42.3

307.7

907

113

N07BB01

ATC

disulfiram; oral

11.0

307.7

4481

2250

P19

ICPC

Drug abuse

7.5

307.7

701

492

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

9.6

307.7

642

349

N03AF01

ATC

carbamazepine; oral, rectal

3.0

307.7

2880

5209

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

11.1

307.7

7774

4069

H02AB06

ATC

prednisolone; systemic

1.4

307.7

26936

111853

F41.01

ICD-10 Finland

Severe panic disorder

40.6

307.7

527

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

50.7

307.7

494

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

11.9

307.7

4111

1905

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

307.7

31301

133206

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.0

307.7

6172

5794

F60.5

ICD-10 Finland

Anankastic personality disorder

17.7

307.7

891

265

N03AX09

ATC

lamotrigine; oral

14.7

307.7

4932

1868

N06AB03

ATC

fluoxetine; oral

34.0

307.7

17819

3659

SPAT1235

SPAT

Mental health, emotional support

11.4

307.7

523

240

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.9

307.7

1907

2622

J02AC01

ATC

fluconazole; systemic

1.5

307.7

21689

82777

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

307.7

15149

51388

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

307.7

16316

55112

N06AB10

ATC

escitalopram; oral

43.0

307.7

33815

8015

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

307.7

7445

21777

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

48.0

307.7

441

F41.1

ICD-10 Finland

Generalized anxiety disorder

12.6

307.7

5874

2638

SPAT1310

SPAT

Counselling related to known health issue

1.5

307.7

17534

67424

P27

ICPC

Fear of mental disorder

7.0

307.7

948

711

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

34216

134429

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

37.7

307.7

1601

226

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.6

307.7

1597

1121

N06AA06

ATC

trimipramine; systemic

24.2

307.7

1971

435

N02AX02

ATC

tramadol; systemic, rectal

1.8

307.7

25903

91501

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.2

307.7

3254

2148

IGV01

NOMESCO Finland

Psychiatric network contact

13.7

307.7

910

349

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

37.4

307.7

542

IBA01, ,

SPAT

5.6

307.7

1484

1410

P15

ICPC

Chronic alcohol abuse

7.7

307.7

2703

1895

S06.0

ICD-10 Finland

Concussion

2.0

307.7

6603

17822

F61.0

ICD-10 Finland

Mixed personality disorders

36.8

307.7

1681

243

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.6

307.7

1021

624

R42

ICD-10 Finland

Dizziness and giddiness

1.8

307.7

13673

43126

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.6

307.7

2564

2450

N06AX17

ATC

milnacipran; oral

90.3

307.7

875

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

307.7

12624

45703

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

21.5

307.7

10419

2954

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.0

307.7

1776

2362

N05CD07

ATC

temazepam; oral

6.1

307.7

10140

9809

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

11.4

307.7

1523

708

P29

ICPC

Psychological sympt/compl other

5.6

307.7

7199

7333

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

307.7

23396

80899

A04

ICPC

Weakness/tiredness general

2.2

307.7

10723

27371

N05AB01

ATC

dixyrazine; systemic

13.8

307.7

968

369

N06AX18

ATC

reboxetine; oral

69.4

307.7

1000

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

7.2

307.7

1466

1082

N01

ICPC

Headache

1.9

307.7

7091

20261

F99

ICD-10 Finland

Mental disorder, not otherwise specified

9.1

307.7

1686

980

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

34200

141233

F32.0

ICD-10 Finland

Mild depressive episode

7.4

307.7

2335

1688

P01

ICPC

Feeling anxious/nervous/tense

5.3

307.7

12951

15037

P03

ICPC

Feeling depressed

9.4

307.7

11518

7541

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

13.2

307.7

1591

638

N05AD03

ATC

melperone; systemic

7.2

307.7

925

677

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

72.3

307.7

7096

569

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

130.3

307.7

5905

258

M01AB05

ATC

diclofenac; systemic, rectal

1.5

307.7

38880

168060

N06AA04

ATC

clomipramine; systemic

37.5

307.7

1497

212

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

307.7

6360

17262

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

307.7

4845

10808

N02BE01

ATC

paracetamol; systemic, rectal

1.9

307.7

57225

261338

F41.09

ICD-10 Finland

UNS Panic Syndrome

13.8

307.7

2934

1152

SPAT1216

SPAT

Assessment of functional ability

1.8

307.7

7744

23816

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

52.8

307.7

1297

130

N05AB03

ATC

perphenazine; systemic, rectal

13.4

307.7

3281

1329

N05AL01

ATC

sulpiride; systemic

22.7

307.7

1251

291

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

17518

64414

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

307.7

3650

8698

F22.0

ICD-10 Finland

Delusional disorder

5.7

307.7

900

825

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

307.7

41615

185548

P06

ICPC

Sleep disturbance

3.2

307.7

9653

17568

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

29527

119956

J01AA02

ATC

doxycycline; systemic

1.5

307.7

46405

209838

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

307.7

5441

13643

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

36.0

307.7

365

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

25.2

307.7

2731

587

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.6

307.7

1727

2000

R02

ICPC

Shortness of breath/dyspnoea

1.9

307.7

7779

22761

N03AE01

ATC

clonazepam; systemic

6.8

307.7

4602

3711

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.7

307.7

2299

1058

P72

ICPC

Schizophrenia

7.7

307.7

1434

991

SPAT1246

SPAT

Screening of depression or other psychiatric problem

2.6

307.7

2581

5272

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

18.4

307.7

596

170

SFA30

NOMESCO Finland

Three-surface restoration

1.4

307.7

23861

97881

IHZ02, ,

SPAT

5.3

307.7

1027

1020

F41

ICD-10 Finland

Other anxiety disorders

6.6

307.7

1347

1084

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

53.4

307.7

591

N05BA06

ATC

lorazepam; systemic, sublingual

7.6

307.7

4511

3275

SPAT1241

SPAT

Extensive assessment of psychosocial situation

6.9

307.7

849

642

N05BA02

ATC

chlordiazepoxide; systemic

13.1

307.7

2097

859

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

5.1

307.7

1082

1124

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.6

307.7

3153

3059

IHZ05, ,

SPAT

5.5

307.7

3999

3987

A03FA02

ATC

cisapride; oral, rectal

2.2

307.7

3907

9729

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

12.0

307.7

2363

1053

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.8

307.7

2800

1714

F40.1

ICD-10 Finland

Social phobias

18.6

307.7

2736

797

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

16779

53325

N05BE01

ATC

buspirone; oral

32.4

307.7

3255

547

P76

ICPC

Depressive disorder

23.7

307.7

8260

2053

N05AX08

ATC

risperidone; systemic

6.8

307.7

8066

6885

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

307.7

3463

7519

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

20.8

307.7

1403

358

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

11.1

307.7

895

426

N06AX21

ATC

duloxetine; oral

14.8

307.7

10979

4554

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

307.7

17782

54163

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

16.1

307.7

548

178

N06AX22

ATC

agomelatine; oral

80.7

307.7

2252

150

N06AA12

ATC

doxepin; systemic

17.1

307.7

4481

1452

N03AX16

ATC

[U] pregabalin

2.7

307.7

14888

33236

N05AX12

ATC

aripiprazole; systemic

18.7

307.7

4638

1377

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

14.2

307.7

656

242

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

307.7

12709

45150

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

14.5

307.7

2410

891

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

22.8

307.7

544

125

N05AH03

ATC

olanzapine; systemic

12.3

307.7

6980

3269

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

16.0

307.7

2312

775

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

307.7

4579

11387

N06AB06

ATC

sertraline; oral

44.4

307.7

17742

2795

IBA03

NOMESCO Finland

Psychotherapy evaluation

13.7

307.7

721

276

N05AN01

ATC

lithium; oral

17.0

307.7

2305

730

SPAT1263

SPAT

Sampling

1.4

307.7

23780

97053

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

17.7

307.7

532

157

G04BD12

ATC

mirabegron; oral

1.9

307.7

5950

17051

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

307.7

18412

65143

N05BA01

ATC

diazepam; systemic, rectal

5.8

307.7

11955

12471

N05AA01

ATC

chlorpromazine; systemic, rectal

9.2

307.7

937

537

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

12.4

307.7

1410

603

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

16072

53776

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

307.7

7100

20922

F31

ICD-10 Finland

Bipolar affective disorder

20.7

307.7

1124

287

N02BF02

ATC

pregabalin; oral

3.3

307.7

4256

7090

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.8

307.7

3361

4816

P20

ICPC

Memory disturbance

1.9

307.7

6890

19407

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

36879

156970

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

21.1

307.7

717

178

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

25938

100558

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

12717

40875

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

44.6

307.7

401

SPAT1240

SPAT

Therapeutic discussion

5.6

307.7

9826

10307

F60.8

ICD-10 Finland

Other specific personality disorders

21.3

307.7

525

129

A28

ICPC

Limited function/disability NOS

1.8

307.7

9118

27942

SPAT1301

SPAT

No procedures

1.5

307.7

17346

65325

N30.0

ICD-10 Finland

Acute cystitis

1.6

307.7

9263

31271

N05AH04

ATC

quetiapine; oral

13.2

307.7

21415

11944

F32.9

ICD-10 Finland

Depressive episode, unspecified

19.6

307.7

17111

5992

N05BA04

ATC

oxazepam; oral

8.5

307.7

28090

27287

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

43.8

307.7

2045

250

L01

ICPC

Neck symptom/complaint

1.7

307.7

9227

29585

IEY01

NOMESCO Finland

Psychoeducation, individual

14.3

307.7

631

231

L17

ICPC

Foot/toe symptom/complaint

1.5

307.7

17546

65257

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

43.9

307.7

3580

447

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

24.7

307.7

490

104

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

26.6

307.7

1202

239

F41.00

ICD-10 Finland

Moderate panic disorder

24.5

307.7

1494

324

IGY99

NOMESCO Finland

Other psychiatric treatment contact

13.8

307.7

1965

762

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

12446

41141

V03AB30, ,

ATC

12.4

307.7

525

221

A10BA02

ATC

metformin; oral

1.5

307.7

15113

55955

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

307.7

3088

7051

R06AE07

ATC

cetirizine; oral

1.5

307.7

26166

103302

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

22776

87077

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

307.7

9688

29702

L28

ICPC

Limited function/disability (L)

1.9

307.7

10375

30854

F41.3

ICD-10 Finland

Other mixed anxiety disorders

9.6

307.7

1323

731

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

18.2

307.7

1746

511

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

8.9

307.7

11677

8075

R51.80

ICD-10 Finland

Headache

2.1

307.7

9882

26879

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

307.7

5484

15234

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.1

307.7

9211

8842

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.8

307.7

1041

809

N06AB05

ATC

paroxetine; oral

38.0

307.7

7820

1205

N05AC02

ATC

thioridazine; oral

5.9

307.7

1324

1184

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

14.6

307.7

697

251

L03

ICPC

Low back symptom/complaint

1.7

307.7

17632

59774

P16

ICPC

Acute alcohol abuse

7.6

307.7

1292

904

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

14.7

307.7

3405

1265

N06AX03

ATC

mianserin; oral

28.3

307.7

4758

937

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

307.7

26836

107262

G47.3

ICD-10 Finland

Sleep apnoea

2.2

307.7

15152

41549

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

307.7

3074

6399

N06BA12

ATC

lisdexamfetamine; oral

7.6

307.7

804

555

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

18.4

307.7

1183

340

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

26.1

307.7

962

194

L02

ICPC

Back symptom/complaint

1.8

306.1

5810

17520

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

305.9

4852

13816

P02

ICPC

Acute stress reaction

2.2

305.5

3146

7614

WZA10, ,

SPAT

5.1

304.8

847

873

SPAT1265

SPAT

Breathalyser

7.2

304.3

627

457

A29

ICPC

General symptom/complaint other

1.7

303.6

7245

23335

ZXE00

NOMESCO Finland

One hour or less

1.4

303.5

21215

86232

F60.7

ICD-10 Finland

Dependent personality disorder

43.3

303.4

315

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

303.1

10762

38255

M02AA07

ATC

piroxicam; topical

1.4

302.6

18323

72583

ICB01, ,

SPAT

7.3

302.5

619

447

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

302.2

8431

28289

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

300.5

3037

7291

IHZ07, ,

SPAT

9.0

300.5

532

310

R01AD08

ATC

fluticasone; nasal

1.5

299.8

15663

60331

M01AH01

ATC

celecoxib; oral

1.6

299.6

8780

29818

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10835

38110

1.57

321.70

2.5

2.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15667

59739

1.47

319.29

1.8

1.11

1.27

mg/l

5.34

11853

46315

(3004789) Transferrin [Mass/volume] in Serum or Plasma

11851

42777

1.53

312.84

2.5

2.7

2.38

2.32

g/l

18.77

10776

39899

(40758558) Short blood count panel - Blood

20437

82200

1.42

312.56

6.8

6.2

—

(3033658) Prothrombin time (PT) actual/Normal

17661

69228

1.44

310.32

4.4

4.1

91.23

89.08

23.66

17212

67759

(3019069) Monocytes/Leukocytes in Blood

32509

130930

1.56

307.65

6.9

6.6

8.67

8.86

27.60

30448

123537

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

56685

268219

1.62

307.65

17.1

13.8

85.59

83.06

ml/min/173m2

136.33

52512

244726

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

18244

63378

1.68

307.65

1.4

1.3

1.42

1.85

u/ml

4.47

4823

17880

(36304419) Bacteria [Presence] in Urine

18926

72086

1.51

307.65

3.5

3.1

28.28

225.28

estimate

0.70

308

(3013650) Neutrophils [#/volume] in Blood by Automated count

38724

158984

1.63

307.65

10.8

9.2

4.17

4.11

e9/l

5.59

33550

137936

(3000850) Epithelial cells [#/volume] in Urine

15881

59782

1.50

307.65

2.9

2.7

5.85

5.23

e6/l

5.41

14376

54456

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

45819

194028

1.71

307.65

4.1

2.9

50.06

44.90

u/l

23.47

43181

184010

(3024561) Albumin [Mass/volume] in Serum or Plasma

31225

117481

1.71

307.65

4.9

5.2

36.05

35.79

g/l

12.16

29189

110456

(3021589) Normoblasts [#/volume] in Blood

29578

125421

1.40

307.65

12.1

10.8

0.00

e9/l

1.24

23854

102738

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

12156

42856

1.58

307.65

2.0

1.8

—

(3044889) 12 lead EKG panel

43318

188342

1.55

307.65

4.2

3.7

0.49

2213.26

1.23

365

(3006315) Basophils [#/volume] in Blood

35410

141997

1.62

307.65

6.8

6.3

0.04

e9/l

0.82

30427

122767

(3015377) Calcium [Moles/volume] in Serum or Plasma

25182

86218

1.83

307.65

3.2

3.6

2.35

mmol/l

0.69

22948

78745

(3026782) Osmolality of Urine

13740

50842

1.51

307.65

3.1

2.9

520.96

547.27

mosm/kgh2o

31.72

12011

44853

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

13420

28966

2.76

307.65

2.2

1.5

1.54

1.38

87.63

11777

25913

(3019198) Lymphocytes [#/volume] in Blood

36048

145328

1.62

307.65

6.8

6.3

1.95

1.91

e9/l

3.44

31736

128550

(3013826) Glucose [Moles/volume] in Serum or Plasma

39011

160879

1.62

307.65

5.5

4.8

6.66

6.69

mmol/l

1.24

37061

150969

(40768797) Stomach Pathology biopsy report

10308

34586

1.65

307.65

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

59387

283414

1.75

307.65

18.5

14.0

23.19

24.68

mg/l

20.92

50261

229175

(3002030) Lymphocytes/Leukocytes in Blood

33205

134916

1.55

307.65

6.8

6.5

28.08

27.92

1.84

31416

128600

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7729

24572

1.72

307.65

2.7

2.5

46.79

51.73

u/l

0.24

6513

21007

(3018010) Neutrophils/Leukocytes in Blood

32659

132355

1.55

307.65

6.7

6.3

57.15

57.24

0.68

31136

127031

(3011288) Drugs identified in Urine by Screen method Nominal

4592

6424

3.91

307.65

3.8

2.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

60452

281834

2.12

307.65

21.1

16.3

139.54

139.70

mmol/l

42.76

59316

275945

(3018095) Leukocytes [#/volume] in Urine

25678

102753

1.48

307.65

4.3

3.8

88.18

98.35

e6/l

0.96

18052

71347

(3018418) pH of Serum or Plasma

21543

76017

1.69

307.65

4.1

4.5

7.40

0.18

15300

53892

(3006504) Eosinophils/Leukocytes in Blood

32468

130566

1.56

307.65

6.8

6.5

2.83

2.85

0.69

30381

123134

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

24753

97130

1.51

307.65

3.7

3.4

2.41

1.99

e6/l

0.23

(3022948) Iron [Moles/volume] in Serum or Plasma

12691

46047

1.53

307.65

2.5

2.7

13.34

13.75

umol/l

0.45

11688

43271

(3001122) Ferritin [Mass/volume] in Serum or Plasma

34630

134137

1.70

307.65

3.4

3.0

110.30

124.46

ug/l

17.15

32280

126438

(3023103) Potassium [Moles/volume] in Serum or Plasma

60499

282495

2.11

307.65

21.2

16.5

3.96

3.97

mmol/l

21.17

59277

276019

(3037467) Urinalysis macro (dipstick) panel - Urine

44215

191868

1.57

307.65

5.0

4.2

11.98

46.49

0.35

301

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

25257

99663

1.51

307.65

4.1

3.4

53.79

60.21

ng/l

0.30

16676

66612

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

52092

211430

2.24

307.65

5.0

4.0

14.49

14.78

pmol/l

131.48

48240

194860

(3024666) Lithium [Moles/volume] in Serum or Plasma

1225

447

14.49

307.65

12.8

15.8

0.61

0.64

mmol/l

2.10

1128

414

(44816559) Phosphatidylethanol [Mass/volume] in Blood

5413

8280

3.61

307.65

2.0

1.5

0.31

0.29

mg/l

0.91

2724

3823

(3001604) Monocytes [#/volume] in Blood

35307

141669

1.62

307.65

6.7

6.3

0.58

e9/l

0.97

30359

122500

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

15511

50531

1.77

307.65

1.8

1.7

17069817.45

38078964.16

pmol/l

6.08

12871

42478

(3019309) Folate [Moles/volume] in Red Blood Cells

13832

37695

2.14

307.65

1.8

1.7

1144.59

1143.48

nmol/l

0.04

10544

28703

(3028707) Methadone [Presence] in Urine by Screen method

3520

2325

8.25

307.65

3.3

2.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8317

22394

2.06

307.65

2.2

2.4

374.15

383.59

nmol/l

3.49

7637

20986

(3031040) Bacteria [#/volume] in Urine by Automated count

42896

181473

1.63

307.65

5.3

4.2

2180.50

1337.08

e6/l

1.52

676

2524

(3035350) Ketones [Presence] in Urine by Test strip

34919

151533

1.41

307.65

4.2

3.6

5.39

3.74

estimate

0.86

7468

30852

(3013115) Eosinophils [#/volume] in Blood

36316

146519

1.62

307.65

7.2

6.4

0.19

e9/l

0.38

31723

128523

(3009261) Glucose [Presence] in Urine by Test strip

35046

152672

1.40

307.65

4.2

3.6

0.11

0.32

estimate

1.16

7072

29218

(3028300) Cannabinoids [Presence] in Urine

5387

11928

2.46

307.65

2.9

1.5

—

(3015736) pH of Urine

29056

119377

1.47

307.65

3.7

3.2

6.24

6.20

7.60

16119

67247

(3027944) Amphetamines [Presence] in Urine

5236

11859

2.40

307.65

2.8

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

50114

208712

1.97

307.65

8.4

8.0

78.08

78.72

u/l

2.10

47517

198703

(3030467) Casts [#/volume] in Urine by Automated count

19750

75773

1.50

307.65

3.5

3.2

0.40

0.41

e6/l

0.38

14444

55094

(3000764) Benzodiazepines [Presence] in Urine

5372

11768

2.49

307.65

2.9

1.5

—

(4198724) Urine methamphetamine measurement

878

631

7.31

307.65

2.7

2.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

32127

120000

1.75

307.65

2.6

2.4

2869.16

76.60

nmol/l

0.50

29350

109927

(3016879) Cocaine [Presence] in Urine

5179

10702

2.64

307.65

2.9

1.5

—

(3032080) INR in Blood by Coagulation assay

29888

123187

1.47

307.65

13.9

14.5

1.22

1.26

inr

36.95

25072

102759

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1224

656

9.86

307.65

15.7

17.1

1884.83

1601.48

nmol/l

0.08

1196

631

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1175

702

8.83

307.65

2.1

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25557

90204

1.76

307.65

3.5

3.2

33.82

33.67

u/l

0.06

23993

85597

(3020564) Creatinine [Moles/volume] in Serum or Plasma

61811

301769

1.78

307.65

23.0

17.9

76.35

77.83

umol/l

23.27

61121

298182

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

731

452

8.49

307.65

2.5

2.8

148.65

155.44

nmol/l

0.42

639

402

(3023368) Bacteria identified in Blood by Culture

19292

72991

1.52

307.65

4.7

4.2

—

(42870588) Differential panel, method unspecified - Blood

24213

92632

1.56

307.65

6.3

6.6

7.00

5.38

—

(3009508) Creatinine [Moles/volume] in Urine

23743

93004

1.50

307.65

3.6

3.5

7.81

7.85

mmol/l

0.68

20068

79962

(3021601) Nitrite [Presence] in Urine by Test strip

34556

149733

1.41

307.65

4.2

3.5

0.00

estimate

0.60

7366

30290

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

22075

78311

1.69

307.65

2.4

2.1

231.53

207.20

u/l

1.58

20837

74234

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

56832

264556

1.74

307.65

5.6

4.6

5.97

5.86

mmol/l

57.87

52590

245624

(3021960) Folate [Moles/volume] in Serum or Plasma

21551

68734

1.93

307.65

1.8

1.6

20.00

19.89

nmol/l

0.45

18690

58821

(3007164) IgA [Mass/volume] in Serum or Plasma

15663

55603

1.60

307.65

1.5

2.36

2.38

g/l

0.54

9420

35914

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1277

702

9.62

307.65

20.6

23.7

2169.32

2355.60

nmol/l

0.05

1236

677

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

19915

68296

1.73

307.65

2.4

2.3

2.76

2.81

mg/l

2.49

17079

59270

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

47851

203429

1.77

307.65

4.5

4.1

11.36

11.45

mm/h

0.64

44769

191254

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

36288

140299

1.75

307.65

6.3

6.5

10.74

11.90

umol/l

49.18

34331

133982

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

57963

256251

2.26

307.65

6.4

4.7

1.81

1.91

mu/l

31.69

54450

238522

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

55462

260128

1.61

307.65

6.9

5.7

39.07

38.85

mmol/mol

5.93

52044

245373

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

34866

129865

1.82

307.65

7.1

7.4

1.21

mmol/l

0.80

30081

112516

(3009466) Valproate [Moles/volume] in Serum or Plasma

2204

2137

5.51

307.65

6.0

4.7

366.17

364.12

umol/l

0.19

1936

1853

(3022096) Basophils/Leukocytes in Blood

32456

130589

1.56

307.65

6.9

6.6

0.68

0.00

30347

123036

(3027008) Opiates [Presence] in Urine

5369

11886

2.46

307.65

2.8

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12438

42955

1.62

307.65

3.2

3.7

0.82

mmol/l

3.90

11626

40615

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

31506

115243

1.79

307.65

6.5

6.8

1.21

mmol/l

4.67

29145

107007

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10099

34794

1.60

307.65

2.4

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

32081

112079

1.93

307.65

2.3

2.0

97.12

95.67

pmol/l

5.68

17588

60593

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

23702

83770

1.73

307.65

3.0

2.6

62.80

70.22

u/l

0.44

21798

78240

(3002582) Erythrocytes [#/volume] in Urine

22634

88292

1.50

307.65

3.6

3.3

70.34

90.53

e6/l

1.17

17231

67011

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

14413

47964

1.71

307.65

2.8

3.1

2.44

2.45

mmol/l

8.83

12794

43017

(3048689) Calprotectin [Mass/mass] in Stool

10874

35249

1.72

307.65

2.4

2.7

125.72

135.58

ug/g

1.89

8516

28476

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

735

655

5.88

303.11

2.5

1.6

143.44

106.57

umol/l

1.63

358

306

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9831

34451

1.57

293.68

5.4

6.8

1.03

1.04

mmol/l

3.53

9112

32192

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

61292

300276

1.67

288.62

13.4

10.8

27.71

26.50

u/l

20.75

59671

292103

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1159

1670

3.65

283.01

1.7

1.3

1.37

1.20

promille

2.43

903

1375

(3021387) Prolactin [Units/volume] in Serum or Plasma

3777

10161

1.99

279.39

1.7

321.12

281.84

mu/l

7.03

3387

9326

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

9041

31432

1.57

277.96

1.9

1.7

—

(3013512) EKG study

21474

88536

1.38

275.66

3.8

3.5

0.77

0.75

0.13

220

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10831

39497

1.51

267.55

2.5

2.8

22.50

23.04

3.36

9931

37028

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7321

24402

1.63

266.79

2.4

0.22

0.21

g/l

7.93

6724

22954

(36660697) Celiac disease serology panel - Serum

6681

21796

1.66

264.45

1.2

—

(3042517) Benzodiazepines panel - Urine

311

23.53

264.03

3.2

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8807

30781

1.56

263.35

2.6

2.9

7.67

9.19

umol/l

7.76

7505

27323

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8517

29574

1.57

261.82

2.0

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

7438

25297

1.59

248.53

2.7

2.2

12.92

13.06

nmol/l

0.70

6616

23286

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13195

50742

1.44

246.75

4.1

3.7

300.67

579.65

ng/l

9.64

9655

38787

(3019150) Specific gravity of Urine by Refractometry

16388

65535

1.40

245.95

4.2

3.7

1.20

1.11

kg/l

0.29

10748

42991

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5230

16303

1.72

243.44

3.0

3.8

4.46

4.57

pmol/l

10.41

4614

14925

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18529

75886

1.37

239.54

3.1

3.2

1154.99

1486.86

ng/l

18.60

15380

65547

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5681

18292

1.67

234.66

1.7

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5271

16681

1.70

231.92

3.5

3.7

5.18

5.10

kpa

9.80

5044

15888

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

12873

49768

1.43

231.72

1.3

31.44

36.12

iu/ml

0.78

3478

15544

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12365

47587

1.43

227.61

3.2

2.9

1.33

1.05

e6/l

0.57

6449

25186

(3009343) pH of Capillary blood

5123

16218

1.69

224.81

3.5

3.7

7.41

7.42

0.91

4313

13450

(3037522) Nuclear Ab [Titer] in Serum

10289

38326

1.47

224.51

1.4

449.48

551.22

titre

6.62

1992

8141

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2670

6890

2.06

219.63

1.5

1.4

282.44

272.43

ug/g

1.11

1489

4041

(3017143) Hepatitis C virus Ab [Presence] in Serum

9606

35595

1.47

214.15

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

19417

81207

1.34

213.71

4.4

3.7

0.01

0.00

estimate

0.42

6894

27743

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

11851

45739

1.42

212.81

1.3

9.21

12.15

u/ml

4.46

4509

18485

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2643

6881

2.04

212.28

2.1

1.8

197.70

203.99

pmol/l

1.95

2495

6590

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3347

9503

1.87

210.26

2.1

1.7

39.10

41.93

nmol/l

8.05

3269

9333

(3011397) Hemoglobin [Presence] in Urine by Test strip

16414

67050

1.36

209.81

4.0

3.5

0.24

0.23

0.06

112

657

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4520

14143

1.71

206.13

3.3

3.6

1.72

1.65

mmol/l

0.67

3383

10143

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11415

43992

1.42

205.74

3.3

3.0

2.92

2.65

e6/l

1.35

5433

21502

(3014111) Lactate [Moles/volume] in Serum or Plasma

6804

23707

1.55

202.00

7.6

8.0

1.36

1.34

mmol/l

0.62

6646

23273

(46235355) HIV 1 and 2 tests - Meaningful Use set

15222

61777

1.36

201.20

2.2

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

15740

64416

1.35

196.31

5.0

4.5

—

14.80

—

(3023183) Ammonium ion [Moles/volume] in Plasma

2032

4924

2.18

195.36

2.6

2.7

32.81

34.00

umol/l

0.98

1845

4438

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

5813

19705

1.58

193.82

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

20595

88061

1.31

188.39

4.3

8.58

9.05

mg/mmol

0.58

12748

56127

(3012516) Albumin [Mass/volume] in Urine

20227

86382

1.31

186.10

3.6

46.88

52.87

mg/l

2.78

12918

56102

(3021447) Carbon dioxide [Partial pressure] in Venous blood

7385

26698

1.49

183.52

4.0

4.1

5.88

5.80

kpa

8.70

7163

26085

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

25913

114642

1.28

181.03

4.2

3.5

0.43

0.50

estimate

0.15

6155

24872

(3002032) Base excess in Venous blood by calculation

7195

25986

1.49

179.33

4.0

4.1

1.83

1.68

mmol/l

2.41

6339

22716

(3012544) pH of Venous blood

7443

27120

1.48

177.52

4.0

4.1

7.38

0.01

4288

16007

(3019225) pH of Specimen

6582

23476

1.51

173.83

3.9

4.2

7.36

1.84

4770

16835

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6356

22624

1.51

169.18

2.5

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

3013

8872

1.80

167.98

1.5

8.41

9.51

u/l

4.79

2378

7222

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5432

18710

1.55

167.83

2.3

2.0

—

(3003396) Base excess in Arterial blood by calculation

8065

30201

1.44

166.25

8.0

7.9

1.05

0.78

mmol/l

7.22

6716

24710

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2272

6116

1.96

165.97

1.3

501.89

555.90

mg/l

2.50

2164

5880

(3024354) Oxygen [Partial pressure] in Venous blood

6215

22107

1.51

165.75

3.5

3.4

4.59

4.57

kpa

0.31

6005

21543

(3027801) Oxygen [Partial pressure] in Arterial blood

8099

30404

1.44

164.60

8.0

7.9

11.92

12.78

kpa

37.42

7785

29218

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8102

30418

1.44

164.58

8.0

7.9

5.15

5.05

kpa

15.94

7786

29232

(3019977) pH of Arterial blood

8104

30453

1.44

163.76

8.0

7.9

7.42

0.89

4444

16290

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5593

19571

1.53

160.66

3.8

4.0

1.23

mmol/l

0.08

4694

17090

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

4589

15380

1.59

158.95

4.0

4.4

24.29

24.09

mmol/l

3.78

4514

15205

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

4061

13239

1.63

157.23

1.1

1.94

13.05

u/ml

2.09

154

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7676

28792

1.43

156.02

7.2

6.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

57434

283241

1.36

155.88

6.0

5.3

2.69

2.74

mmol/l

26.61

53596

266898

(3023323) Follitropin [Units/volume] in Serum or Plasma

4260

14088

1.61

155.73

1.4

22.71

26.54

iu/l

11.14

3547

12150

(3027945) Reticulocytes/Erythrocytes in Blood

8073

30599

1.42

154.90

2.4

2.7

1.78

1.74

2.67

7101

27521

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2952

8894

1.76

152.22

2.1

2.4

475.24

605.65

ug/l

1.30

2781

8395

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2025

5413

1.97

150.68

1.4

1.5

1655.81

1603.62

e6/l

0.03

1608

4249

(3022145) Colonoscopy Study observation

8103

30896

1.41

149.97

1.4

—

(3042936) Bacteria identified in Isolate by Culture

9809

38653

1.37

149.48

2.2

2.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

49896

241643

1.28

149.35

22.8

17.0

13.60

13.53

23.20

49253

238360

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2004

5354

1.97

149.33

1.4

20.42

37.06

e6/l

2.15

1488

3960

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4339

14561

1.59

149.10

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5471

19412

1.51

146.63

1.2

122.29

153.38

u/ml

5.68

1927

7551

(3000494) Fungus identified in Specimen by Culture

8512

32869

1.40

146.16

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2017

5444

1.95

146.03

1.3

3.79

3.71

mmol/l

2.83

1915

5153

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

53933

264237

1.30

143.28

4.4

4.0

1.38

1.25

mmol/l

264.05

49727

247075

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5036

17646

1.52

142.93

7.8

8.6

24.94

24.63

mmol/l

6.89

4983

17536

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

25690

115859

1.25

140.40

2.0

1.9

1.47

1.32

mmol/l

97.41

21586

99219

(3016502) Oxygen saturation in Arterial blood

7179

27124

1.42

138.99

8.3

95.32

95.76

6.22

6953

26141

(3025941) Bacteria identified in Stool by Culture

4307

14685

1.56

137.92

1.3

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10250

41152

1.35

137.42

2.0

2.2

29.50

29.70

2.48

9957

40087

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

56657

280028

1.32

134.29

5.3

4.7

4.58

4.64

mmol/l

44.23

53083

264927

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6749

25438

1.42

131.93

3.9

3.2

—

(3017732) Neutrophils [#/volume] in Blood

8797

34685

1.37

131.88

3.6

3.0

4.61

4.50

e9/l

0.45

7548

30261

(3013139) Helicobacter pylori Ag [Presence] in Stool

5094

18219

1.49

130.65

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1283

3058

2.20

127.96

1.7

384.85

353.36

mu/l

1.06

1025

2530

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

16009

69000

1.27

125.71

2.4

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2836

8911

1.68

125.59

3.5

3.9

24.85

24.71

mmol/l

1.86

2642

8222

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2806

8797

1.69

125.28

2.8

2.9

24.84

24.45

mmol/l

5.78

2760

8634

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

56275

278431

1.31

124.92

5.2

4.6

1.40

1.46

mmol/l

203.97

52385

262156

(3023511) Choriogonadotropin [Units/volume] in Urine

1921

5417

1.87

122.12

1.5

1.3

—

(3007461) Platelets [#/volume] in Blood

62547

314916

1.45

119.60

29.0

20.9

255.05

250.28

e9/l

59.79

61404

308249

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

62558

315105

1.44

117.05

29.5

21.3

40.62

41.28

5.18

61900

311759

(3035941) MCH [Entitic mass]

62554

315084

1.44

116.99

28.8

20.8

30.31

30.25

11.51

61903

311919

(3024731) MCV [Entitic mean volume] in Red Blood Cells

62552

315086

1.44

116.70

28.8

20.8

90.94

90.71

28.15

61903

311914

(3010813) Leukocytes [#/volume] in Blood

62566

315189

1.44

116.31

29.0

20.9

6.88

6.70

e9/l

51.14

61244

307537

(3026361) Erythrocytes [#/volume] in Blood

62556

315130

1.44

116.29

28.9

20.9

4.50

4.53

e12/l

35.05

61222

307471

(3000963) Hemoglobin [Mass/volume] in Blood

62560

315226

1.44

114.81

29.1

21.0

135.47

136.22

g/l

29.85

61923

312102

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6626

25479

1.39

114.39

8.9

8.7

122.52

121.57

g/l

2.98

6490

24867

(3005719) IgG [Mass/volume] in Serum or Plasma

5626

21087

1.42

112.32

2.4

3.0

10.49

10.74

g/l

3.54

5153

19648

(40761536) Microorganisms panel - Urine sediment

5734

21571

1.42

112.15

4.4

3.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3801

13210

1.52

110.93

1.1

123.49

192.22

titre

0.93

440

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2208

6740

1.73

108.24

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2219

6784

1.72

108.20

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

2222

6804

1.72

107.73

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

651

1210

2.81

107.63

1.0

761.81

741.45

ng/l

0.42

448

869

(3008295) Osmolality of Serum or Plasma

1014

2354

2.26

107.51

1.6

1.4

280.08

279.79

mosm/kgh2o

0.13

777

1846

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

651

1212

2.81

107.32

1.0

40.03

41.45

ng/l

0.31

454

891

(3003181) Sodium [Moles/volume] in Urine

1497

4052

1.94

107.28

1.5

1.4

60.52

63.59

mmol/l

1.74

1145

3286

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

649

1207

2.81

107.19

1.0

289.49

380.59

ng/l

2.18

464

898

(3014051) Protein [Presence] in Urine by Test strip

18674

83112

1.23

106.69

3.1

2.8

0.11

0.07

0.81

352

1762

(3023520) Reticulocytes [#/volume] in Blood

6086

23351

1.39

105.93

2.3

2.8

71.20

68.52

e9/l

5.94

4359

17206

(1616796) Gas panel - Central venous blood

1897

5586

1.79

105.04

3.7

—

(3010421) pH of Blood

2458

7795

1.66

104.84

3.7

3.5

7.41

1.48

2409

7698

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4343

15707

1.47

104.40

9.6

10.1

24.39

24.14

mmol/l

5.04

4217

15369

(3041096) Erythrocytes [Presence] in Urine by Automated

18688

83444

1.23

102.56

3.6

3.0

0.33

0.22

estimate

0.46

6088

23969

(3005322) IgE [Units/volume] in Serum or Plasma

4976

18528

1.43

102.55

1.3

306.57

242.85

u/ml

1.17

4618

17320

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5016

18744

1.42

101.30

2.4

21.02

21.07

au/ml

0.01

515

2267

(3026493) Urate [Moles/volume] in Serum or Plasma

16693

73739

1.23

101.15

2.6

2.8

339.87

344.49

umol/l

6.61

14550

66171

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3823

13577

1.49

100.44

3.2

3.0

1.40

1.19

20.08

3806

13515

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5193

19558

1.41

100.34

3.6

4.4

85.61

93.31

ng/l

6.52

4466

17137

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2993

10083

1.57

100.02

1.6

1.7

15.06

16.83

u/ml

0.56

647

2737

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4659

17243

1.43

99.08

1.3

41.91

53.53

au/ml

3.12

236

1146

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

28810

134606

1.20

97.23

2.8

2.7

—

estimate

—

(3007463) Buprenorphine [Presence] in Urine

108

28.10

95.98

7.5

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

4444

16400

1.44

95.85

1.8

2.0

1.26

1.31

g/l

0.67

4063

15197

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2281

7260

1.65

95.85

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3773

13498

1.48

95.49

3.2

3.0

0.62

0.63

0.22

3762

13455

(3027315) Oxygen [Partial pressure] in Blood

1737

5136

1.78

94.82

4.0

3.8

8.75

8.68

kpa

0.74

1686

5031

(3012501) Base excess in Blood by calculation

1727

5103

1.78

94.48

4.0

3.8

2.50

2.44

mmol/l

0.33

1182

3375

(3013290) Carbon dioxide [Partial pressure] in Blood

1727

5104

1.78

94.42

4.0

3.8

5.07

4.95

kpa

7.08

1676

4999

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

116

+∞

91.92

1.4

0.0

527.75

—

nmol/l

—

116

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2287

7367

1.63

91.70

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2415

7896

1.61

91.27

2.1

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4474

16700

1.42

90.48

10.2

10.4

0.63

0.64

0.14

4450

16603

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4586

17216

1.41

89.81

10.0

10.1

1.42

1.28

14.21

4564

17100

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1656

4918

1.77

89.06

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1655

4917

1.77

88.89

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5381

20837

1.37

87.66

2.4

2.2

6.86

7.93

ug/l

2.22

4579

18488

(3007566) Smooth muscle Ab [Titer] in Serum

2336

7659

1.61

87.24

1.2

1.3

86.69

124.41

titre

2.78

245

735

(3028626) Oxygen [Partial pressure] in Capillary blood

2069

6579

1.65

87.17

3.1

3.3

8.29

8.37

kpa

1.18

2024

6405

(3014007) Fractional oxyhemoglobin in Arterial blood

4574

17268

1.40

86.62

10.1

10.3

93.62

94.09

4.99

4558

17215

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3484

12517

1.47

86.08

2.5

2.4

5055.42

6504.11

u/l

1.93

1225

5504

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

604

1226

2.57

85.02

1.8

1.3

1890065.83

1632701.79

iu/ml

0.16

(3020779) Urea [Moles/volume] in Serum or Plasma

6156

24465

1.34

84.69

6.7

8.3

9.04

10.19

mmol/l

28.87

5861

23387

(3002179) Metamyelocytes/Leukocytes in Blood

5897

23291

1.35

84.53

4.1

4.4

0.68

0.72

0.41

1697

7052

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2906

10095

1.52

84.42

1.3

1.2

0.73

0.94

u/ml

0.49

213

773

(40767503) Oxygen content in Capillary blood by calculation

1702

5184

1.72

83.92

2.7

2.5

16.81

16.63

1.47

1668

5056

(3020891) Body temperature

3266

11651

1.48

83.53

5.0

4.4

36.94

36.89

°c

8.32

3230

11547

(3017181) Myelocytes/Leukocytes in Blood

6148

24546

1.33

81.82

4.3

4.5

0.88

0.94

0.77

1798

7402

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

714

1608

2.32

81.12

1.7

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5498

21612

1.35

81.12

2.4

2.8

66.55

66.40

g/l

0.68

5000

19978

(3021901) Oxygen saturation in Capillary blood

1699

5228

1.71

80.78

2.9

3.0

90.27

90.20

0.15

1658

5073

(3034770) Mitochondria Ab [Titer] in Serum

2255

7505

1.58

79.07

1.2

1.3

791.43

1080.37

titre

0.91

217

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

12147

53048

1.23

78.40

1.7

—

(3025159) Blasts/Leukocytes in Blood

5938

23744

1.33

77.97

4.7

0.11

0.40

5.51

1438

6197

(3006653) Thiamine [Moles/volume] in Blood

525

1040

2.64

77.47

1.3

1.2

141.19

135.00

nmol/l

1.75

525

1040

(3021440) Promyelocytes/Leukocytes in Blood

5878

23530

1.33

76.52

4.4

4.6

0.09

0.12

2.16

1539

6421

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2824

9960

1.49

76.22

1.7

4.04

4.28

mg/l

0.56

2255

6895

(3028271) Lactate [Moles/volume] in Capillary blood

1290

3724

1.82

76.09

2.0

1.8

1.75

1.74

mmol/l

0.14

1263

3608

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

806

1970

2.14

75.73

2.0

2.7

19.62

20.05

nmol/l

0.48

746

1889

(3004119) Hemoglobin [Mass/volume] in Venous blood

4294

16420

1.38

75.01

3.5

3.4

130.71

129.47

g/l

2.82

4174

16009

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1318

3852

1.79

74.71

1.4

1.3

23.11

26.00

u/l

2.32

1059

3243

(3052851) Hemolysis interference index of Serum or Plasma

2126

7099

1.57

73.47

3.3

3.2

1.91

2.33

index

1.51

1120

3629

(3021879) Hepatitis B virus core Ab [Presence] in Serum

6013

24295

1.31

73.13

1.5

—

(3045414) Leukocytes [Presence] in Urine

6375

25983

1.30

72.75

2.1

2.0

0.02

estimate

0.40

1292

5578

(3023410) Appearance of Cerebral spinal fluid

926

2478

1.95

68.58

1.5

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1182

3444

1.80

67.69

1.6

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

926

2492

1.94

67.50

1.2

29.61

38.60

nmol/l

0.51

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4138

16020

1.36

66.74

7.4

6.7

24.78

24.35

mmol/l

10.13

3984

15282

(3016650) Hepatitis A virus Ab [Presence] in Serum

1478

4637

1.67

65.44

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

170

165

5.36

65.21

1.7

1.1

0.94

—

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

5068

33615

0.77

64.37

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1253

3785

1.73

63.58

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7484

31665

1.26

62.76

5.0

4.7

31.30

32.52

16.22

5158

21758

(3018405) Lactate [Moles/volume] in Arterial blood

2266

7948

1.50

62.65

4.3

4.1

1.37

1.40

mmol/l

0.50

2232

7775

(3024928) Oxygen saturation in Venous blood

1931

6544

1.55

62.53

3.2

3.4

61.90

62.86

1.01

1830

6338

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1880

6382

1.55

60.41

2.3

2.2

132.01

130.78

g/l

1.22

1474

4908

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2464

8890

1.46

59.18

2.3

2.6

0.68

0.86

g/l

1.81

2130

7694

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1452

4671

1.63

58.40

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3410

13083

1.37

57.94

4.4

3.9

49.09

47.02

4.83

3353

12917

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4929

19996

1.30

57.50

3.0

168.65

217.48

ng/l

12.50

4459

18336

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2055

7192

1.50

57.39

2.3

2.4

0.00

g/l

0.78

1793

6356

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

179

208

4.48

57.19

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7558

32426

1.24

55.46

3.7

4.7

234.88

245.25

u/l

6.14

7104

30969

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2744

10250

1.41

54.56

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

859

2426

1.85

54.37

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

5452

22571

1.28

54.27

2.5

0.41

0.38

e6/l

0.39

5230

21565

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2122

7566

1.47

54.09

2.3

2.4

0.04

0.02

g/l

0.64

1896

6853

(3004716) Salmonella sp identified in Stool by Organism specific culture

3609

14127

1.35

53.90

1.3

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1927

6754

1.50

53.42

2.4

2.5

0.00

g/l

-0.00

1787

6347

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2631

9805

1.41

52.99

2.2

2.4

2.90

2.89

g/l

0.19

2398

8964

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2528

9385

1.42

52.02

2.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2733

10298

1.40

51.65

2.1

1.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

1896

6686

1.49

51.03

4.6

4.4

3.85

3.90

mmol/l

5.21

1886

6621

(3022806) Fractional oxyhemoglobin in Capillary blood

968

2895

1.75

50.91

1.9

1.7

89.80

90.05

0.58

952

2845

(3008898) HLA-B27 [Presence]

2615

9815

1.40

50.54

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

628

1640

2.00

49.91

3.1

27.92

24.20

mu/l

1.56

588

1544

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2753

10448

1.38

49.84

2.2

2.4

7.38

7.34

g/l

0.65

2521

9604

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2750

10435

1.39

49.84

2.2

2.4

4.23

4.20

g/l

0.92

2518

9599

(3040151) Glucose [Moles/volume] in Capillary blood

962

2894

1.74

49.60

8.4

5.5

7.34

mmol/l

0.01

802

2364

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2745

10424

1.38

49.51

2.2

2.4

3.71

3.74

g/l

0.52

2514

9588

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1382

4579

1.58

49.32

1.5

0.35

0.43

nmol/l

1.90

1032

3642

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2402

8952

1.41

48.32

2.2

2.4

10.02

10.33

g/l

2.78

2139

8022

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2119

7739

1.44

47.66

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

6056

38070

0.81

47.36

1.9

3.54

3.50

ratio

1.27

4523

28928

(4024509) Urine culture

3065

11957

1.35

46.67

2.0

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2035

7406

1.44

46.64

1.1

3.49

6.61

eliau/ml

4.21

256

1019

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

723

2040

1.85

45.98

1.1

284.38

429.27

mg/l

0.52

647

1889

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3856

15610

1.30

45.33

10.1

16.14

16.16

0.12

3727

15047

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1085

3463

1.64

45.08

1.9

7227.23

2842.78

titre

0.98

144

(3016038) Potassium [Moles/volume] in Urine

561

1480

1.98

43.44

1.3

32.16

35.62

mmol/l

2.75

468

1336

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2186

8164

1.40

43.43

1.3

35.82

41.36

u/ml

0.34

104

449

(3001019) Free T4 and TSH panel - Serum or Plasma

3576

14417

1.31

43.29

1.7

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2990

11760

1.34

43.08

1.9

2.1

39.67

39.68

u/l

0.01

2685

10549

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

687

1952

1.84

42.80

1.3

1.2

1.99

2.15

mmol/l

2.95

640

1815

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1787

13036

0.70

42.28

1.1

0.62

0.63

ratio

0.09

203

1466

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2310

8758

1.38

42.02

1.8

1.21

1.17

g/l

7.27

2207

8403

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2251

8511

1.39

41.62

1.8

0.24

0.23

g/l

2.52

2147

8128

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

388

907

2.23

40.83

1.4

1.5

73.73

72.67

0.74

371

868

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2048

7644

1.40

40.83

2.0

8.44

18.23

iu/l

0.63

838

3170

(3027273) Bicarbonate [Moles/volume] in Venous blood

3017

11995

1.32

40.32

3.7

3.5

25.38

25.17

mmol/l

2.56

2915

11609

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1012

3266

1.62

40.30

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2925

11581

1.33

40.24

1.9

7.57

8.10

iu/ml

0.27

694

2724

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2675

10455

1.34

40.16

2.0

1.9

2.01

2.45

ug/l

0.86

2360

9314

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

4500

28688

0.80

39.67

1.6

3.44

3.48

mmol/l

1.31

3022

19330

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

380

892

2.22

39.63

1.4

1.5

518.28

746.01

mu/l

0.85

363

853

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2959

11766

1.32

39.50

1.4

1.7

12.82

14.54

iu/ml

0.25

381

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

988

3186

1.62

39.48

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1997

14118

0.73

38.90

1.2

1.1

0.88

0.89

g/l

0.56

1989

14082

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

420

1037

2.11

38.78

2.7

2.6

56.26

51.35

umol/l

2.16

360

916

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1469

5204

1.48

38.69

1.7

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

987

3200

1.61

38.61

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

1566

5626

1.46

38.42

3.1

3.2

61.98

63.33

1.50

1559

5607

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

723

2165

1.74

38.00

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1651

6011

1.44

37.77

1.2

37.88

47.98

u/ml

1.37

140

544

(3022621) pH of Urine by Test strip

5260

22600

1.23

37.17

2.7

2.4

6.12

6.07

3.61

3460

14864

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2554

10077

1.33

35.95

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

508

1390

1.91

35.58

1.1

3.44

7.43

nmol/l

1.45

273

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2023

7720

1.37

35.36

1.3

3.68

6.86

u/ml

1.56

184

742

(3003129) Base excess in Capillary blood by calculation

915

2978

1.60

35.28

2.0

2.2

0.75

0.27

mmol/l

3.42

887

2837

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3099

12593

1.29

35.24

1.6

1.8

1.55

1.50

g/l

1.84

2622

10845

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

398

1004

2.07

34.87

2.5

2.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

340

806

2.20

34.73

2.0

2.8

1.12

1.09

ug/l

0.08

318

769

(3005988) Vibrio sp identified in Specimen by Organism specific culture

931

3059

1.59

34.54

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1108

3796

1.53

34.27

1.1

1.49

1.50

g/l

0.44

996

3502

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

928

3055

1.59

34.16

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

926

3048

1.59

34.11

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2012

7720

1.37

34.01

1.3

6.98

9.01

u/ml

0.79

279

1126

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

551

1574

1.83

33.88

1.3

5.31

5.39

umol/l

0.16

479

1413

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1075

3674

1.53

33.63

1.3

0.22

0.27

nmol/l

0.36

218

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

5076

21946

1.22

33.61

2.7

70.28

66.95

ml/min/173m2

6.47

2163

9058

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.99

33.44

2.1

2.0

262.32

229.66

ug/l

0.44

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

104

122

4.44

33.10

1.1

1.4

57.96

42.87

mg/l

1.49

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1060

3625

1.53

33.07

1.3

0.99

1.80

nmol/l

0.54

1016

3508

(3045424) Erythrocytes [Presence] in Urine

3270

13488

1.27

33.03

2.2

2.1

0.01

0.10

estimate

0.88

981

4383

(3013005) Retinol [Moles/volume] in Serum or Plasma

428

1137

1.96

32.67

1.7

2.0

1.97

1.93

umol/l

0.46

386

1045

(3036180) Methadone [Presence] in Urine

43.35

32.55

3.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

319

760

2.19

32.25

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2022

7852

1.35

31.66

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1481

5467

1.42

31.47

2.1

2.2

0.90

0.83

nmol/l

2.54

1241

4669

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

318

765

2.17

31.43

3.0

3.1

29.16

28.79

umol/l

0.16

227

597

(3048929) Epstein Barr virus Ab [Presence] in Serum

2605

10518

1.30

31.07

1.3

—

(3017509) Phencyclidine [Presence] in Urine

154

258

3.11

30.68

2.1

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

785

2548

1.61

30.68

1.4

1.3

1.52

1.40

nmol/l

1.68

695

2319

(3011985) Renin [Units/volume] in Plasma

1089

3816

1.49

30.34

1.6

69.42

56.65

mu/l

0.89

973

3471

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

49101

247441

1.11

30.06

24.3

17.4

332.73

332.82

g/l

1.47

48806

245930

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

319

783

2.12

30.04

1.4

13.70

15.50

pmol/l

5.36

260

684

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

667

2091

1.66

29.87

1.2

1.1

37.15

48.27

mg/l

6.20

564

1802

(3019832) Treponema pallidum Ab [Presence] in Serum

8030

36521

1.16

29.59

2.0

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1305

4762

1.43

29.57

1.5

1.6

0.72

0.81

g/l

1.89

1000

3737

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

924

3145

1.53

29.51

1.3

0.19

0.28

nmol/l

0.65

694

2521

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

477

1365

1.82

29.26

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

288

686

2.19

29.20

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

996

3469

1.50

28.61

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

642

2018

1.66

28.49

1.1

248.98

281.82

mg/l

2.66

572

1815

(3006270) Folate [Moles/volume] in Blood

593

1835

1.69

27.91

1.2

1.1

378.00

356.13

nmol/l

1.58

508

1551

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2906

12060

1.26

27.87

5.3

4.7

1.77

1.60

9.36

2758

11441

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1761

6829

1.35

27.85

1.5

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

609

1903

1.67

27.65

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

418

1168

1.87

27.65

1.2

1.3

65.69

64.47

0.07

148

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1807

7043

1.34

27.65

1.5

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1687

6507

1.36

27.63

1.2

1.3

2.10

5.89

u/ml

2.92

474

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

583

1804

1.69

27.45

1.2

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

441

1258

1.83

27.37

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1895

7453

1.33

27.28

1.2

4.18

3.95

0.29

232

1185

(3006922) Hepatitis E virus Ab [Presence] in Serum

686

2223

1.61

27.06

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

576

1785

1.68

26.99

1.1

1.3

—

(40768443) Skin Pathology biopsy report

2973

12420

1.26

26.95

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3023

19315

0.80

26.80

1.5

1.6

1010.69

1021.33

mu/l

0.17

2548

16640

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1940

7681

1.32

26.68

1.9

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1004

3558

1.47

26.54

6.4

6.2

11.59

11.63

mg/l

0.10

924

3299

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

875

3020

1.51

26.28

2.0

26.05

26.84

mg/l

0.15

310

1137

(3047181) Lactate [Moles/volume] in Blood

2003

7986

1.31

26.22

5.9

5.4

1.35

1.30

mmol/l

1.24

1762

7065

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

997

3538

1.47

26.18

1.4

362.30

368.21

pmol/l

0.04

842

3051

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.58

26.16

1.1

—

mmol/l

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

510

1546

1.72

25.89

1.3

1.2

0.59

0.65

ratio

1.30

298

914

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

426

1226

1.81

25.75

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9720

45206

1.14

25.74

1.6

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2183

8832

1.29

25.65

3.0

3.5

38.56

46.75

mg/l

1.84

1821

7548

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1364

5151

1.38

25.49

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1977

7902

1.31

25.42

1.5

14.87

12.92

iu/ml

0.21

177

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

888

3099

1.50

25.33

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1594

6180

1.35

25.28

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

2181

8844

1.29

25.19

3.0

3.6

72.07

62.42

mg/l

0.19

1824

7554

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

766

2595

1.54

25.07

1.2

1.3

—

titre

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1730

6802

1.33

24.99

1.3

11.96

17.42

u/ml

0.20

(3020911) Cortisol [Moles/time] in 24 hour Urine

314

825

1.98

24.88

1.4

1.5

218.00

224.09

nmol/24h

0.02

314

825

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1092

3987

1.43

24.75

1.4

—

(3036489) Thrombin time

2629

10942

1.26

24.60

1.9

2.2

20.88

21.05

0.65

2322

9646

(3027923) C peptide [Moles/volume] in Serum or Plasma

482

1468

1.71

24.11

1.7

1.5

1.26

nmol/l

0.06

348

1157

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

409

1188

1.79

24.04

1.7

1.6

4.46

6.03

nmol/l

0.29

316

1007

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

958

3437

1.45

23.84

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

186

404

2.40

23.30

1.6

1.8

0.90

1.16

nmol/l

0.71

(3017315) Amylase [Enzymatic activity/volume] in Urine

433

1292

1.75

23.29

1.2

339.23

353.71

u/l

0.07

397

1209

(4146454) Self-monitoring of blood glucose

759

2610

1.52

23.26

2.7

2.8

—

(3011648) Oxygen content in Venous blood

793

2755

1.50

23.16

2.3

2.7

11.08

11.13

0.10

787

2744

(3029634) Reagin Ab [Titer] in Serum by VDRL

1168

4372

1.40

23.05

2.4

2.2

12.58

6.77

titre

0.72

116

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2219

9125

1.27

22.96

2.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

760

5784

0.68

22.87

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2510

10490

1.25

22.67

1.3

230.33

225.52

miu/ml

0.24

1081

4987

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1726

6882

1.31

22.63

1.1

2.09

2.35

u/ml

0.45

935

3652

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

579

1886

1.60

22.48

1.1

—

0.25

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

464

1429

1.69

22.35

1.1

1.08

1.14

u/l

0.58

185

586

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1866

7538

1.29

22.22

2.0

2.1

11.58

11.47

mg/l

0.14

1766

7096

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

370

1070

1.80

22.11

1.8

1.9

28.11

28.53

umol/l

0.32

345

1000

(3007930) Methemoglobin/Hemoglobin.total in Blood

2618

11028

1.24

22.05

5.6

4.9

0.88

0.09

2486

10430

(3037121) Protein [Mass/volume] in Urine

2248

9310

1.26

21.95

3.2

3.5

489.92

486.74

mg/l

0.01

1032

4562

(3023419) Bacteria identified in Sputum by Culture

896

3226

1.45

21.94

2.5

2.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

275

722

1.98

21.91

1.2

19.21

22.00

0.18

125

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1938

7882

1.29

21.91

2.9

3.5

5.21

5.82

ratio

0.11

1067

4565

(3045716) Anion gap in Serum or Plasma by calculation

772

2701

1.49

21.84

3.0

3.1

10.60

10.77

mmol/l

0.56

759

2672

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1327

5123

1.35

21.70

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1465

5743

1.33

21.65

1.1

1.08

1.02

u/ml

0.14

663

2564

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

653

2217

1.54

21.26

1.4

1.3

181.14

191.99

pmol/l

0.25

653

2217

(3014271) Vancomycin [Susceptibility]

353

1021

1.80

21.12

3.2

2.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

258

671

2.00

21.12

1.4

1.2

129.96

130.20

nmol/l

0.01

181

511

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1204

4604

1.37

20.93

1.6

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

460

1448

1.66

20.49

1.6

1.5

19.52

23.96

umol/l

2.85

423

1352

(3024139) IgG subclass 3 [Mass/volume] in Serum

816

2927

1.45

20.41

1.4

0.37

0.42

g/l

3.14

583

2122

(3003888) Timothy IgE Ab [Units/volume] in Serum

1511

6002

1.32

20.39

1.1

5.33

5.76

u/ml

0.39

822

3242

(3027135) IgG subclass 1 [Mass/volume] in Serum

816

2930

1.45

20.31

1.4

6.35

6.89

g/l

3.88

584

2125

(4062490) Immunoglobulin typing, IgG

803

2877

1.46

20.22

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

815

2929

1.45

20.20

1.4

2.87

3.02

g/l

1.53

584

2127

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

485

1555

1.63

20.13

1.3

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1225

4736

1.35

19.89

1.9

5.11

5.16

mmol/24h

0.18

1104

4262

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

450

1424

1.65

19.67

1.5

5.79

6.05

u/l

0.19

382

1212

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1431

5677

1.32

19.51

1.1

1.58

2.02

u/ml

1.25

756

2820

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

476

1534

1.62

19.38

1.3

1.4

—

(3049717) Cytology report of Urine Cyto stain

2355

9956

1.24

19.22

2.5

2.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1294

5072

1.33

19.19

1.2

1.3

144.55

131.11

titre

0.08

108

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1016

3836

1.38

19.14

1.2

13.56

20.34

u/ml

0.63

161

(3044242) Glucose [Moles/volume] in Arterial blood

413

1295

1.66

18.72

2.2

1.8

8.07

8.14

mmol/l

0.13

413

1295

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

575

1954

1.53

18.72

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

253

684

1.93

18.66

1.3

16.49

16.28

umol/l

0.25

214

599

(40757494) Bilirubin.total [Moles/volume] in Blood

378

1165

1.69

18.28

2.0

2.1

13.31

27.55

umol/l

1.85

105

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

345

1037

1.73

18.24

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1973

12665

0.80

18.23

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

183

446

2.14

17.80

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

1802

7457

1.26

17.78

1.1

—

(3042631) Mycobacterium sp identified in Specimen

895

3351

1.39

17.76

2.7

2.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1270

5035

1.32

17.45

1.2

1.3

305.00

304.00

titre

0.01

374

(3008116) Ketones [Moles/volume] in Urine by Test strip

207

534

2.02

17.43

1.6

1.3

0.23

0.40

mmol/l

0.97

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

366

1136

1.68

17.29

1.1

9.90

10.51

u/ml

0.09

205

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1595

6533

1.28

17.14

1.2

1.3

32.62

47.23

u/ml

1.06

105

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

891

3355

1.39

17.12

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

587

2045

1.50

17.09

1.2

1.3

2.20

1.94

u/ml

0.21

340

1198

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1089

4240

1.34

16.96

1.3

—

23.45

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

6.68

16.92

1.4

1.1

1.90

2.08

g/l

0.28

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

560

1938

1.51

16.83

1.4

12.06

12.68

umol/l

1.16

524

1849

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

527

1801

1.52

16.79

1.4

1.6

25.93

26.05

u/ml

0.02

111

324

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

273

787

1.81

16.65

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1499

6123

1.28

16.48

1.2

1.3

253.65

252.74

u/ml

0.04

926

3922

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1478

6032

1.28

16.36

2.3

2.5

111.37

113.35

ug/min

0.05

869

3689

(3037756) Immunofixation for Serum or Plasma

1322

5319

1.30

16.34

1.5

1.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

465

1555

1.56

16.34

1.2

1.3

540.00

455.05

titre

0.13

109

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

453

1506

1.57

16.33

1.2

1.3

70.30

87.38

titre

0.37

107

(3035320) C reactive protein [Mass/volume] in Body fluid

582

2044

1.48

16.32

3.1

2.4

27.44

29.63

mg/l

0.63

420

1464

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1112

4380

1.32

16.03

1.3

1.5

18.03

12.32

u/ml

0.57

(3028717) Thiamine [Mass/volume] in Blood

135

303

2.32

15.96

1.2

64.97

62.13

ug/l

0.68

135

303

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

901

3443

1.36

15.87

1.5

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1194

4764

1.31

15.72

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

604

2156

1.46

15.64

1.2

111.78

111.27

pmol/l

0.08

604

2156

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

270

795

1.77

15.41

3.7

2.5

10.06

10.56

kpa

1.63

270

795

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

270

795

1.77

15.41

3.7

2.5

4.99

4.87

kpa

1.03

270

795

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1447

9419

0.79

15.22

1.5

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

888

3412

1.36

15.13

1.3

—

(3017569) Oxygen content in Arterial blood

395

1296

1.59

15.10

2.6

2.0

16.03

16.00

0.06

395

1296

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1243

5030

1.29

14.76

1.1

4.58

3.87

u/ml

0.46

621

2540

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2017

8634

1.22

14.70

2.2

2.7

190.51

189.31

0.22

1908

8235

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

184

2.66

14.66

1.5

1.3

9.85

15.93

pmol/l

1.07

152

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

345

1103

1.63

14.66

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

345

1103

1.63

14.66

1.3

1.4

—

(3025130) Human papilloma virus identified in Specimen

1130

4520

1.30

14.64

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

267

798

1.74

14.53

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2060

8848

1.22

14.52

3.2

0.34

iu/ml

0.00

1135

4786

(3039162) Centromere protein B Ab [Units/volume] in Serum

885

3423

1.35

14.48

1.2

1.3

65.66

53.44

u/ml

0.47

209

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

405

1351

1.56

14.46

1.3

—

(3002256) Pathology report gross observation

7979

37841

1.11

14.41

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

165

423

2.03

14.24

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

737

2778

1.38

14.18

1.2

61.14

65.27

u/l

0.62

640

2458

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

624

2285

1.42

14.17

1.2

152.98

210.96

titre

1.04

104

356

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1150

4636

1.29

14.08

1.2

1.3

31.10

32.66

u/l

0.13

982

4074

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

622

2280

1.42

14.06

1.2

207.06

178.05

titre

0.11

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3088

13796

1.17

14.02

3.1

3.5

57.58

53.20

u/ml

0.16

2974

13365

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1106

7357

0.78

14.00

1.5

1.6

58.42

60.39

ug/l

0.80

1106

7357

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1231

5011

1.28

13.99

1.1

17.68

15.62

au/ml

0.40

283

1479

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2158

9361

1.20

13.75

2.0

2.5

94.47

92.77

2.72

2066

9030

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

137

333

2.14

13.56

1.0

81.37

81.67

ug/l

0.03

112

263

(3041806) Other cells [#/volume] in Blood by Manual count

353

1160

1.58

13.47

1.5

1.4

0.52

e9/l

0.02

353

1160

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1167

4746

1.28

13.38

1.1

6.14

4.55

u/ml

1.28

537

2149

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

726

2767

1.37

13.10

1.5

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

657

2466

1.39

13.02

3.8

4.0

—

(3051611) Lipemic interference index of Serum or Plasma

676

2550

1.38

13.00

3.5

14.46

13.30

index

1.21

413

1459

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

212

615

1.79

12.81

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2039

8864

1.20

12.73

1.4

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

149

386

2.01

12.57

2.0

1.9

—

(3001556) Androgen free Index in Serum or Plasma

116

272

2.22

12.54

1.3

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

106

239

2.31

12.52

1.9

2.0

1.35

1.33

umol/l

0.23

173

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

454

1604

1.47

12.51

1.9

1.7

—

(3000012) Reticulocyte production index

926

3687

1.31

12.49

2.1

2.3

0.94

0.90

0.89

626

2530

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

213

626

1.77

12.36

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

414

1442

1.49

12.24

1.5

—

(44813793) Dust mix specific IgE antibody measurement

534

1956

1.42

12.20

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1692

10581

0.83

12.15

1.5

1.6

60.71

62.90

ug/l

1.07

1408

8935

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2082

9114

1.19

12.07

2.3

2.7

3.65

3.58

g/l

1.12

1976

8764

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

136

346

2.04

12.06

2.1

2.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1128

4631

1.27

12.05

1.1

70.96

841.74

iu/ml

1.33

233

940

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

323

1072

1.57

11.90

1.1

334.98

368.87

ng/l

0.06

313

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2038

8919

1.19

11.86

3.4

3.9

1.47

1.52

mg/l

1.74

1871

8261

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1437

6079

1.23

11.82

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

457

1638

1.45

11.74

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

175

492

1.85

11.72

1.3

1.18

mmol/l

0.08

175

492

(3039000) Anion gap in Blood by calculation

1299

5441

1.25

11.70

7.2

6.5

11.25

11.34

mmol/l

0.38

1169

4900

(3018572) Chloride [Moles/volume] in Blood

1299

5442

1.25

11.68

7.2

6.5

104.98

105.22

mmol/l

0.95

1169

4903

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

426

1510

1.47

11.59

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

18623

92226

1.07

11.55

5.2

5.3

2.66

3.36

ug/l

2.01

16558

84233

(3021788) Differential panel - Synovial fluid

1218

5075

1.25

11.50

1.5

1.6

1.00

0.95

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

297

975

1.59

11.48

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1295

8260

0.81

11.39

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

200

592

1.76

11.38

1.9

2.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

451

1627

1.44

11.23

1.4

1.6

8.18

8.90

ug/l

0.25

410

1492

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1000

4083

1.28

11.20

1.1

2.04

3.05

3.23

156

735

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1321

8393

0.81

11.19

1.5

1.6

—

(3051651) Icteric interference index of Serum or Plasma

420

1496

1.46

11.18

3.7

3.9

0.91

0.90

index

0.03

412

1459

(3020491) Glucose [Moles/volume] in Blood

525

1949

1.40

11.18

1.8

1.7

6.93

6.58

mmol/l

1.62

384

1438

(4034850) Laboratory test

1866

8147

1.20

11.17

11.0

9.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1601

9970

0.83

11.02

1.4

1.5

1.16

1.17

ratio

0.12

956

6038

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1606

9994

0.83

10.97

1.4

1.5

1.24

1.17

ratio

1.83

967

6117

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1606

9994

0.83

10.97

1.4

1.5

0.95

ratio

0.29

962

6063

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

111

2.86

10.94

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1034

4255

1.27

10.89

1.1

0.49

0.33

u/ml

0.59

347

1235

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

794

3160

1.31

10.83

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

513

1908

1.40

10.82

1.1

1.16

2.38

0.44

(3002079) Sodium [Moles/time] in 24 hour Urine

359

1249

1.50

10.75

1.2

1.3

159.76

163.24

mmol/24h

0.33

359

1249

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

849

3414

1.30

10.73

2.0

2.3

32.57

32.63

0.14

844

3392

(3005033) Fetal Nuchal fold Thickness US

1271

8070

0.81

10.72

1.5

1.26

1.25

0.34

907

6020

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1577

9794

0.83

10.56

1.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5824

27605

1.11

10.51

3.7

4.5

20.77

27.91

ug/l

0.65

4671

22217

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

514

1926

1.39

10.41

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

193

583

1.72

10.30

1.1

6.80

7.40

mg/g

0.45

185

555

(3012565) Volume of 24 hour Urine

364

1282

1.48

10.30

1.9

2.2

2001.25

1974.15

0.17

327

1158

(3008757) Leukocyte morphology finding [Identifier] in Blood

681

2674

1.33

10.25

3.1

3.8

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

278

925

1.56

10.22

1.2

110.44

110.13

0.07

253

838

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

656

2564

1.33

10.19

1.5

1.8

—

(3038026) Centromere Ab [Units/volume] in Serum

537

2035

1.37

10.18

1.2

51.46

47.09

u/ml

0.11

126

(3004451) EKG impression Narrative

385

1376

1.46

10.13

1.2

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

718

2850

1.31

10.02

1.2

39.87

45.81

u/ml

0.21

148

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

670

2638

1.32

9.91

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

338

1186

1.48

9.77

3.9

4.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

293

998

1.53

9.74

1.2

0.31

0.30

g/l

0.91

241

793

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

993

4125

1.25

9.71

1.1

2.65

3.12

eliau/ml

0.67

451

2054

(3000475) Leukocytes [#/volume] in Synovial fluid

1542

6714

1.20

9.58

1.6

1.7

13810.00

13757.26

e6/l

0.01

1075

4854

(3028433) Virus identified in Specimen by Culture

245

805

1.58

9.54

1.1

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

1075

4527

1.24

9.34

2.9

3.6

1.38

1.61

1.35

962

4070

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

610

2395

1.33

9.24

1.2

79.91

68.74

u/ml

0.29

(3044927) Protein electrophoresis panel - Urine

608

2389

1.33

9.17

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

133

375

1.84

8.96

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

606

2392

1.32

8.87

2.8

2.7

—

(44790049) Parainfluenza type 3 nucleic acid detection

858

3546

1.26

8.82

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

858

3547

1.26

8.80

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

553

2157

1.33

8.79

1.2

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

858

3549

1.26

8.76

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

565

2212

1.33

8.76

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

565

2212

1.33

8.76

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

565

2212

1.33

8.76

1.5

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

858

3550

1.26

8.74

1.4

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1059

4489

1.23

8.69

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

591

2336

1.32

8.59

1.1

1.2

—

(3051339) Copper [Moles/volume] in Blood

109

2.62

8.58

1.1

1.4

16.52

15.88

umol/l

0.38

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1342

5832

1.20

8.57

1.4

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

148

438

1.76

8.57

1.6

1.5

5.55

6.67

nmol/l

0.60

140

425

(3000330) Specific gravity of Urine by Test strip

2973

13730

1.13

8.56

3.6

3.2

1.02

ratio

1.46

2652

12347

(3035947) Staphylolysin Ab [Units/volume] in Serum

359

1312

1.42

8.49

1.2

1.1

3.83

3.93

iu/ml

0.08

105

(3017354) Segmented neutrophils/Leukocytes in Blood

707

2868

1.28

8.48

2.9

3.6

56.28

57.61

0.87

606

2486

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1017

4306

1.23

8.45

1.1

120.11

116.05

3.68

927

3936

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

412

1544

1.39

8.45

1.5

1.6

6.35

7.03

u/l

0.45

309

1240

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

583

2306

1.32

8.44

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

582

2303

1.32

8.40

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

131

376

1.81

8.39

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

110

298

1.92

8.38

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

182

575

1.65

8.35

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

601

2391

1.31

8.35

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

449

1711

1.37

8.33

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

938

3945

1.24

8.30

2.6

3.1

1494.79

633.82

u/ml

0.40

929

3900

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

145

431

1.75

8.29

2.6

2.4

7.69

mmol/l

0.00

251

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2151

9747

1.15

8.24

1.6

3.05

8.13

iu/ml

0.69

355

1816

(40761539) Cells [Type] in Urine sediment by Light microscopy

182

578

1.64

8.20

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

413

1557

1.38

8.19

1.3

26.25

26.94

u/l

0.08

347

1328

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

140

414

1.76

8.15

1.3

1.4

92.31

285.34

ng/l

0.52

292

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

564

2233

1.32

8.13

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

229

771

1.55

8.12

1.1

5.23

19.99

u/ml

0.58

131

442

(3034274) Bile acid [Moles/volume] in Serum --fasting

1074

4598

1.22

8.04

2.0

2.3

5.86

7.04

umol/l

1.58

770

3411

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

466

1798

1.35

8.01

3.1

3.7

105.48

161.46

nmol/l

2.57

459

1775

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

540

2131

1.32

7.98

1.1

7.14

7.99

iu/ml

0.40

128

612

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

145

437

1.73

7.93

1.5

1.7

0.23

0.21

nmol/l

0.21

117

326

(40768800) Prostate Pathology biopsy report

921

5849

0.82

7.92

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

141

423

1.73

7.84

1.1

0.66

4.06

umol/24h

0.50

210

(37208534) Antinuclear antibody arbitrary concentration in serum

256

891

1.49

7.81

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

167

2.21

7.81

1.6

1.8

41.85

46.43

umol/l

0.58

167

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1051

4509

1.21

7.73

1.1

0.30

3.49

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

367

1372

1.39

7.69

1.9

1.7

2.29

3.00

u/field

0.72

268

969

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

446

1721

1.35

7.69

2.2

2.6

876.10

1079.74

u/ml

0.79

440

1700

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1459

6458

1.18

7.61

1.3

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

420

1609

1.36

7.59

1.3

95.58

96.17

u/l

0.03

362

1387

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1447

6404

1.18

7.56

1.3

1.5

23.62

21.19

u/ml

0.22

122

(3024869) Neuronal Ab [Presence] in Serum

132

393

1.75

7.55

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

557

2226

1.30

7.55

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

441

1704

1.35

7.55

1.0

—

(3018333) Ribosomal P Ab [Presence] in Serum

544

2168

1.31

7.52

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

107

299

1.86

7.50

1.0

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

268

951

1.47

7.47

1.2

0.42

0.38

g/l

0.08

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

189

628

1.57

7.16

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

119

350

1.77

7.12

1.3

86.80

83.19

mmol/24h

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1633

7335

1.16

7.11

1.4

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

320

1187

1.40

7.06

2.2

2.1

102.20

84.39

ug/min

0.22

275

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

420

2882

0.76

7.03

1.6

8.11

7.58

mmol/l

4.60

401

2771

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1099

4784

1.20

6.99

1.2

1.3

3.48

3.68

u/ml

0.14

412

1898

(4015189) Microbial culture of sputum

176

579

1.58

6.97

2.4

2.1

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

106

303

1.82

6.96

1.3

45.27

55.33

1.00

147

(3002619) Bacteria identified in Specimen by Culture

195

659

1.54

6.88

1.2

—

(44806071) Cardiolipin IgM antibody measurement

126

381

1.72

6.88

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1069

4649

1.20

6.87

1.2

1.3

3.61

4.11

u/ml

0.71

484

2267

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

113

332

1.77

6.81

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

268

970

1.44

6.79

1.8

1.9

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

592

2422

1.27

6.75

1.5

1.6

30.77

31.52

0.18

353

1570

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

180

601

1.56

6.71

1.6

0.40

ug/l

0.03

138

433

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

323

1215

1.38

6.60

1.1

0.08

0.45

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

241

1.90

6.60

1.1

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.01

6.59

1.3

31.24

56.63

umol/24h

0.49

(3010370) Gastrin [Moles/volume] in Serum or Plasma

129

399

1.68

6.52

1.9

1.8

36.88

47.31

pmol/l

0.78

112

330

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

246

1.88

6.51

1.1

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

594

2446

1.26

6.45

4.2

5.7

52.79

109.02

u/ml

3.07

174

902

(3005011) Chlamydia sp Ab [Titer] in Serum

112

334

1.74

6.45

1.6

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

124

383

1.68

6.32

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1326

5923

1.17

6.27

1.4

1.5

148.21

150.02

au/ml

0.20

353

1756

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

382

1489

1.34

6.26

1.1

76.86

85.68

u/l

1.55

334

1334

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

160

529

1.57

6.26

1.2

315.45

289.47

pmol/l

0.33

110

396

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

260

952

1.42

6.23

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

214

757

1.47

6.15

1.4

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1114

4922

1.18

6.05

2.5

3.1

860.94

5288.08

u/ml

1.34

292

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

244

889

1.43

6.03

1.1

91.09

88.73

0.48

112

434

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

240

872

1.43

6.02

1.1

93.46

87.97

1.05

114

428

(4195642) Thrombophilia screening test

989

4327

1.19

6.02

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

378

1481

1.33

6.01

1.2

19.69

25.31

u/l

1.48

330

1323

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

202

1.93

5.95

1.1

87.89

99.64

titre

0.62

202

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

431

1723

1.30

5.94

1.8

2.4

100.58

96.32

1.51

401

1623

(3000093) Morphology [Interpretation] in Blood Narrative

643

2701

1.24

5.92

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

512

2097

1.27

5.86

2.1

1.8

1.73

3.02

u/field

0.59

293

1150

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1416

6392

1.15

5.86

4.6

6.2

954.90

1107.56

iu/ml

0.13

136

994

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

107

325

1.71

5.83

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

133

2.15

5.78

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

227

1.86

5.74

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

132

427

1.61

5.69

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

273

1026

1.38

5.69

1.0

11.44

10.89

u/ml

0.13

164

683

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

406

2715

0.78

5.68

1.5

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

232

851

1.42

5.57

5.5

6.4

24.96

25.00

mmol/l

0.05

217

765

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

252

939

1.40

5.54

2.3

2.2

58.97

62.92

ug/l

0.28

247

921

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

110

342

1.67

5.53

2.2

2.5

0.89

1.40

mmol/l

1.51

239

(3008037) Lactate [Moles/volume] in Venous blood

1462

6648

1.15

5.49

3.7

3.0

1.58

1.56

mmol/l

0.33

1441

6502

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

742

3191

1.21

5.48

1.1

1.29

2.16

iu/ml

1.79

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

767

3310

1.21

5.46

1.1

97.92

96.55

0.72

725

3114

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

186

657

1.47

5.45

1.1

—

(3011412) CD3 cells [#/volume] in Blood

639

2711

1.23

5.40

2.5

2.4

1269.34

1178.16

e6/l

1.08

544

2395

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1095

4881

1.17

5.39

3.4

3.2

0.80

0.81

nmol/l

0.26

853

3924

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

245

915

1.39

5.33

1.2

111.15

105.93

1.05

221

835

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

393

1584

1.29

5.17

1.1

1642.70

1489.42

miu/ml

1.93

393

1584

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1321

5995

1.15

5.13

1.5

1.4

122.75

133.91

pmol/l

0.34

1287

5850

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

152

1.98

5.03

1.4

40.97

35.77

0.35

101

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

704

3045

1.20

4.95

3.2

3.5

5.81

9.52

nmol/l

0.76

679

2953

(3034891) Synovial lining cells/cells in Synovial fluid

320

1263

1.32

4.93

1.5

3.68

4.52

0.37

307

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

302

1.67

4.91

1.2

1.1

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

132

2.05

4.91

1.4

14.59

12.53

0.21

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2098

9830

1.11

4.88

1.5

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

108

2.17

4.87

1.2

1.3

1.10

0.94

umol/24h

0.08

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

279

1.70

4.87

2.6

3.5

40.32

43.48

umol/l

0.69

230

(3014148) Varicella zoster virus Ab [Titer] in Serum

979

4364

1.17

4.87

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

147

1.98

4.84

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

461

1913

1.25

4.82

2.6

2.5

0.74

0.66

e9/l

1.62

437

1847

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

262

1008

1.35

4.81

1.9

2.1

39.97

40.50

g/l

0.66

262

1008

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1468

6746

1.13

4.76

1.3

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

4.75

1.0

0.0

339.67

—

ug/l

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

219

1.78

4.75

1.7

1.6

2.21

1.47

mg/l

0.59

142

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

155

544

1.48

4.75

1.1

3.24

7.27

u/ml

0.73

357

(3027231) Wheat IgE Ab [Units/volume] in Serum

167

596

1.46

4.71

1.1

4.73

1.50

u/ml

0.41

144

524

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.48

4.65

1.1

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

128

435

1.53

4.57

1.8

2.5

1.19

1.18

mmol/l

0.50

121

415

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

115

2.08

4.54

1.3

1.70

1.73

0.01

(4268621) Lupus anticoagulant assay

763

3354

1.18

4.53

2.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

720

4422

0.84

4.52

3.3

2.3

13.17

13.12

0.80

714

4365

(37021550) Renin [Units/volume] in Plasma --upright

136

471

1.50

4.47

1.3

85.52

68.36

mu/l

0.36

358

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

389

1600

1.26

4.43

1.9

2.0

96.77

104.75

ng/l

0.82

389

1595

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

217

1.75

4.39

1.2

0.68

0.52

iu/ml

0.34

110

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

265

1.67

4.33

1.2

1.76

1.74

iu/ml

0.03

144

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

242

1.70

4.29

1.0

0.26

1.08

u/ml

1.08

177

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

1.93

3.00

mg/l

0.84

161

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

2.73

1.91

mg/l

0.50

156

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

1.92

1.63

mg/l

0.32

158

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

0.95

0.69

mg/l

0.37

142

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

2.25

2.11

mg/l

0.09

150

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

1.78

1.45

mg/l

0.20

127

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

2.61

1.62

mg/l

0.62

131

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

1.56

1.96

mg/l

0.27

148

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

215

1.74

4.28

1.7

1.6

4.25

4.46

mg/l

0.08

139

(40757373) Influenza virus identified in Isolate

134

470

1.48

4.17

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1285

5915

1.13

4.12

4.0

3.1

27.55

27.76

mg/l

0.07

867

4097

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.40

4.11

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

307

1.59

4.03

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

454

1923

1.23

4.03

2.5

537.11

528.26

e6/l

0.11

350

1563

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

488

2083

1.22

4.02

2.3

2.1

—

(3000060) B lymphocytes [#/volume] in Blood

223

863

1.34

4.02

2.3

2.1

2.13

0.49

e9/l

0.59

101

419

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

204

1.73

4.00

1.3

1.4

16.22

17.26

nmol/l

0.10

(3006571) Granulocytes/Leukocytes in Synovial fluid

738

3273

1.17

4.00

1.6

57.83

56.72

0.29

456

2163

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

333

1363

1.27

4.00

1.7

2.1

143.42

148.52

0.54

309

1290

(21494815) CD4 cells/Lymphocytes in Specimen

582

2529

1.20

3.99

2.4

2.2

40.09

37.98

2.81

567

2484

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1059

4829

1.14

3.95

1.2

1.00

1.11

0.15

224

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

182

1.77

3.93

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

167

1.81

3.91

1.6

1.3

23.26

14.19

pmol/l

0.82

147

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

127

448

1.47

3.88

1.8

2.5

1.20

1.19

mmol/l

0.79

120

427

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

210

1.71

3.88

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

856

3856

1.16

3.81

4.0

3.6

31.02

40.92

u/ml

2.06

828

3711

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

251

1000

1.31

3.74

1.8

2.1

—

(1175426) CD3 cells/Lymphocytes in Blood

510

2206

1.20

3.71

2.2

2.1

74.20

72.32

2.24

483

2136

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

248

988

1.31

3.70

1.8

2.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

155

1.81

3.70

1.0

20.65

17.85

u/ml

0.11

127

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

335

1387

1.26

3.69

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

335

1387

1.26

3.69

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

335

1387

1.26

3.69

1.7

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

248

989

1.30

3.67

1.8

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

335

1388

1.26

3.67

1.7

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

175

1.75

3.64

1.1

8.24

10.81

u/l

0.67

175

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

328

1.54

3.64

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

416

1768

1.22

3.63

1.1

1.2

1.06

ratio

0.10

350

1471

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.05

3.58

1.1

1.2

532.89

336.70

u/l

0.42

(3016750) Collection duration of Urine

354

1481

1.24

3.58

2.1

2.3

514.43

496.97

min

2.82

260

1136

(3036670) Protein [Mass/volume] in Synovial fluid

194

750

1.35

3.57

1.3

1.2

38.79

40.99

g/l

1.10

407

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

132

478

1.44

3.57

2.6

2.8

33.51

47.58

mg/l

0.53

109

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

310

1278

1.26

3.56

1.1

1.2

11.37

10.53

u/ml

0.04

153

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

127

1.88

3.55

1.1

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

293

1200

1.27

3.55

1.0

1.1

99.63

96.44

0.88

232

962

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

688

3067

1.17

3.55

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

273

1.58

3.51

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

463

1996

1.21

3.51

2.7

2.6

234.57

228.93

e6/l

0.21

377

1700

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

128

1.87

3.48

1.2

1.1

1.10

1.17

u/field

0.24

(3010503) CD19 cells [#/volume] in Blood

389

1650

1.23

3.48

2.7

2.5

203.50

343.50

e6/l

0.96

370

1616

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

210

1.66

3.43

1.2

1.1

1.65

3.48

umol/24h

0.54

210

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

107

375

1.48

3.43

2.4

2.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

305

1.53

3.37

1.0

0.63

0.29

u/ml

0.36

193

(21494890) Protein electrophoresis panel - 24 hour Urine

621

2759

1.17

3.37

2.1

—

(40768441) Liver Pathology biopsy report

477

2073

1.20

3.35

1.3

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

184

1.70

3.34

1.0

3.39

2.41

u/ml

0.17

150

(3006245) CD3-CD19+ cells/cells in Blood

281

1157

1.26

3.30

2.4

2.3

8.81

10.87

2.28

262

1079

(3020876) Protein [Mass/time] in 24 hour Urine

770

3487

1.15

3.26

2.3

2.5

1.18

1.30

g/24h

0.68

425

2162

(3011841) English Walnut IgE Ab [Units/volume] in Serum

283

1.54

3.24

1.0

1.88

2.00

u/ml

0.03

219

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1214

5660

1.12

3.24

3.1

3.6

668.62

1139.03

u/ml

0.82

1069

5138

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

487

2128

1.19

3.23

2.2

2.0

14.18

15.33

1.81

471

2075

(3002621) Streptococcal DNAse B [Units/volume] in Serum

271

1.55

3.23

1.0

1.1

355.59

328.26

u/ml

0.10

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.28

3.14

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

664

2984

1.16

3.14

1.3

1.4

9.24

8.07

mmol/l

7.42

619

2871

(44806420) Estimation of glomerular filtration rate

703

3173

1.15

3.13

2.5

2.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

555

2464

1.17

3.08

1.3

1.4

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

169

1.69

3.07

1.3

1.2

18.33

25.29

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

144

1007

0.74

3.03

2.9

3.3

43.06

45.05

0.54

144

1007

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

144

1007

0.74

3.03

5.8

6.5

8.98

8.70

0.24

144

1007

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

1.72

3.03

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

182

1.66

3.01

2.7

3.3

39.27

406.28

pmol/l

0.53

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

214

863

1.29

3.00

1.1

3.30

7.03

u/ml

—

(4035726) Immunohistochemistry procedure

4858

24021

1.05

2.96

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

490

2164

1.18

2.92

1.1

16.13

20.43

u/ml

2.23

220

865

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

251

1038

1.26

2.89

2.7

2.9

0.61

mmol/l

0.19

251

1038

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2057

9896

1.08

2.89

3.1

3.7

731.95

1768.21

u/ml

1.74

1756

8597

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.08

2.88

1.0

229.67

207.70

pmol/l

0.08

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

103

1.87

2.85

1.6

0.00

0.17

u/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

305

1.48

2.85

2.7

2.4

0.60

0.51

u/field

0.43

305

(40762887) Creatinine [Moles/volume] in Blood

181

1.64

2.84

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.47

2.83

1.7

3.5

5.48

2.43

mu/l

0.55

(3016031) Almond IgE Ab [Units/volume] in Serum

214

1.58

2.82

1.0

0.68

0.49

u/ml

0.21

125

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

109

785

0.72

2.81

1.2

71.97

67.17

ug/l

0.41

109

785

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

286

1.49

2.76

1.0

1.1

0.30

2.12

u/ml

1.44

219

(3010144) Erythrocytes [#/volume] in Synovial fluid

563

2527

1.16

2.76

1.4

164557.07

103519.77

e6/l

0.93

381

1636

(3014599) Egg white IgE Ab [Units/volume] in Serum

452

1997

1.18

2.71

1.1

2.65

2.38

u/ml

0.08

128

474

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

341

1470

1.21

2.70

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

107

396

1.40

2.67

1.8

1.5

248241.44

214079.53

nmol/l

0.08

334

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.03

2.65

1.0

3.47

3.36

u/ml

0.01

(3013166) Neutrophils/Leukocytes in Synovial fluid

179

721

1.29

2.59

1.4

52.30

57.01

0.91

155

622

(3020874) Milk IgE Ab [Units/volume] in Serum

462

2056

1.17

2.56

1.1

2.88

2.75

u/ml

0.03

165

626

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

179

724

1.29

2.52

1.7

1.6

9.21

9.34

ug/l

0.14

179

724

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

177

715

1.29

2.52

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

177

715

1.29

2.52

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

177

715

1.29

2.52

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

177

715

1.29

2.52

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

301

1.45

2.51

1.2

—

(3012898) Urea [Moles/volume] in Urine

284

1.46

2.51

1.8

1.4

171.21

171.19

mmol/l

0.00

249

(40762365) Oxygen content in Arterial blood by calculation

366

1.41

2.51

2.9

3.0

14.80

14.77

ml/dl

0.03

341

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

196

1.56

2.50

1.0

0.27

0.15

u/ml

0.22

196

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.16

2.50

1.0

2.81

0.92

u/ml

0.34

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

166

666

1.30

2.49

1.2

10.04

12.26

pmol/l

0.52

256

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

740

3414

1.13

2.47

1.9

2.0

25.62

24.86

ug/l

0.10

727

3353

(3009015) Lactate [Moles/volume] in Synovial fluid

247

1.49

2.46

1.2

1.3

6.16

6.75

mmol/l

0.33

124

(3042111) Morphology [Interpretation] in Bone marrow Narrative

948

4439

1.11

2.44

1.6

1.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

329

1.42

2.44

1.0

0.32

0.83

u/ml

0.57

150

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

264

1123

1.22

2.43

2.2

2.1

28.56

29.80

0.77

249

1070

(3004775) Volume in Urine collected for unspecified duration

453

2025

1.16

2.40

2.2

2.4

685.90

674.32

0.22

321

1409

(3001686) Cold agglutinin [Titer] in Serum or Plasma

118

454

1.35

2.38

1.2

1.4

119.71

297.00

titre

—

(3007916) DNA double strand Ab [Titer] in Serum

310

1.43

2.35

1.3

156.25

121.04

titre

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

107

407

1.37

2.33

1.0

7.22

10.36

u/ml

0.59

107

407

(3024263) Appearance of Synovial fluid

300

1302

1.20

2.27

1.6

1.8

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

193

800

1.25

2.27

1.6

1.7

—

201.94

iu/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

334

1.40

2.27

1.0

4.66

2.78

u/ml

0.16

151

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

380

1685

1.17

2.26

2.7

2.8

39.87

38.54

0.62

206

899

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

152

1.61

2.25

1.0

1.1

59.69

49.88

u/l

0.49

122

(3036603) Volume of Urine

484

2189

1.15

2.22

1.5

1.7

2167.23

1944.34

3.74

475

2135

(3022493) Free Hemoglobin [Mass/volume] in Plasma

297

1291

1.20

2.22

3.1

5.2

775.17

2779.69

mg/l

1.44

205

929

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

165

1.58

2.22

1.2

1.5

23.28

21.75

mmol/l

1.17

117

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.23

2.22

1.2

85.23

62.37

e6/l

0.16

(3052592) Norovirus Ag [Presence] in Stool

118

460

1.33

2.21

1.2

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

344

1516

1.18

2.21

1.1

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

237

1010

1.22

2.18

1.7

2.1

163.28

171.51

0.49

225

956

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

202

847

1.24

2.17

2.2

1.9

1.78

1.76

ratio

0.06

194

823

(3016228) CD19 cells/cells in Blood

250

1073

1.21

2.15

2.2

2.0

8.81

8.08

0.45

240

1056

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

239

1022

1.22

2.14

1.0

0.44

0.79

u/ml

1.36

233

1006

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

460

2087

1.15

2.05

1.7

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

334

1480

1.17

2.04

8.2

6.1

439.63

4351.96

u/ml

0.86

248

(4133840) Spirometry

134

887

0.78

2.00

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

141

1.59

1.99

1.3

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

170

1.53

1.99

1.4

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

286

1.40

1.98

1.1

0.51

7.11

u/ml

0.57

145

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.86

1.98

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

247

1.43

1.97

1.4

1.3

305.92

388.64

mg/24h

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.06

1.97

1.1

2.37

2.98

0.56

(3033086) Enterovirus Ab [Titer] in Serum

1.83

1.96

1.0

—

(3013466) aPTT in Blood by Coagulation assay

154

1.55

1.96

1.2

1.1

36.24

38.25

1.07

131

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

107

420

1.32

1.96

5.4

5.5

43.16

42.00

ug/min

0.06

334

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

331

1473

1.17

1.94

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

492

2253

1.14

1.94

3.0

44.07

57.95

mg/l

0.65

375

1610

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.71

1.92

1.3

1.16

1.11

u/field

0.09

(3019768) Coxiella burnetii Ab [Presence] in Serum

172

1.51

1.90

1.1

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

130

527

1.28

1.89

1.1

—

(3033099) Centromere Ab [Titer] in Serum

168

703

1.24

1.89

1.1

—

(3042733) HLA Ab [Presence] in Serum

173

1104

0.81

1.88

4.8

5.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

147

606

1.26

1.88

1.1

1.2

80.38

87.82

0.96

188

(3024316) Viscosity of Plasma

131

1.59

1.88

1.4

2.0

1.78

1.65

mpas

0.28

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

130

528

1.28

1.87

6.4

7.3

67.33

71.78

0.97

100

416

(3038515) Glucose [Moles/volume] in Venous blood

1174

5637

1.08

1.87

3.9

3.1

7.56

7.54

mmol/l

0.07

1155

5523

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

100

392

1.33

1.86

1.1

1.3

32.50

45.14

mg/l

2.24

332

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

100

392

1.33

1.86

1.0

0.02

0.19

u/ml

0.98

248

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.70

1.86

1.0

1.1

349.01

277.15

nmol/l

0.23

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.96

1.85

6.1

5.3

0.23

0.25

mmol/l

0.13

(40759632) Porphyrins [Mass/mass] in Stool

2.60

1.84

1.4

1.0

—

(3024471) HLA-A [Type]

157

1009

0.81

1.84

1.0

—

(3017704) Immunofixation for Urine

314

1399

1.17

1.83

1.4

1.7

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

161

1.52

1.83

1.6

2.0

213.15

171.82

ug/g

0.84

143

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.91

1.83

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

195

1.47

1.83

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

234

1.42

1.82

1.5

1.4

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

122

494

1.28

1.81

1.1

31.92

32.48

iu/ml

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

345

1.34

1.80

2.9

2.8

74.55

74.92

pmol/l

0.00

302

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

158

1.51

1.78

1.2

1.3

1617.11

871.28

u/l

0.25

144

(4212803) Bone marrow aspirate examination

205

1.45

1.77

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

312

1394

1.16

1.77

2.0

1.8

2.02

2.98

u/ml

0.77

401

(3015076) Soybean IgE Ab [Units/volume] in Serum

406

1850

1.14

1.76

1.0

0.71

1.03

u/ml

0.34

121

419

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

187

801

1.21

1.72

3.1

3.0

1.89

1.82

ratio

0.28

163

741

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

147

1.52

1.71

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

317

1.34

1.70

1.1

—

(3024932) HLA-DR beta [Type]

155

987

0.82

1.69

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

278

1.36

1.67

3.3

3.0

1.16

1.36

mg/l

0.42

189

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

4.33

1.67

2.4

1.8

—

(46235168) Fasting glucose [Moles/volume] in Blood

436

0.73

1.65

2.4

1.3

7.31

7.20

mmol/l

0.09

132

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

111

1.59

1.65

1.1

1.2

2437.82

5046.17

ng/l

1.02

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

145

608

1.24

1.64

1.1

1.2

71.30

76.04

0.42

181

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

288

1.35

1.64

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

212

0.61

1.61

1.6

2.2

21.96

19.66

mmol/l

0.28

183

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

279

1247

1.16

1.61

2.4

2.5

22.68

241.16

ug/l

1.80

263

1200

(3002331) Protein [Mass/volume] in Peritoneal fluid

150

634

1.23

1.59

1.5

1.3

23.41

35.78

g/l

0.75

102

500

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.64

1.58

1.0

1.1

2.19

0.95

u/field

0.54

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

103

417

1.28

1.57

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.71

1.52

1.0

1.1

0.07

0.08

u/ml

0.09

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

230

1.38

1.51

1.0

1.1

0.04

0.07

u/ml

1.05

230

(3045462) Protein/Creatinine [Ratio] in Urine

100

406

1.28

1.51

4.6

4.3

33.05

48.78

mg/mmol

0.83

364

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

225

1368

0.85

1.51

1.2

1.3

953.66

1034.90

titre

0.38

298

(3023487) Leukocytes [#/volume] in Peritoneal fluid

226

1001

1.17

1.49

2.4

1.9

2736.64

3102.21

e6/l

0.05

144

672

(3018738) Hemoglobin F/Hemoglobin.total in Blood

219

0.64

1.46

2.4

3.1

29.12

9.20

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

843

4043

1.08

1.46

1.3

1.4

7.27

7.02

mmol/l

1.48

743

3564

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

378

0.73

1.45

8.2

8.8

0.35

0.34

umol/l

0.03

336

(3047189) Immunofixation for 24 hour Urine

267

1202

1.15

1.44

1.7

1.9

—

(44786800) Granulocytes/Leukocytes in Body fluid

286

1.33

1.44

1.2

1.4

25.53

24.28

0.11

221

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

318

1.31

1.43

1.0

3.54

0.46

u/ml

0.61

151

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

215

1.38

1.42

1.0

1.1

8.87

6.46

u/ml

0.31

125

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

432

2009

1.12

1.42

1.3

1.4

12.74

13.07

u/l

0.40

416

1948

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

304

1384

1.14

1.41

1.4

1.5

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

301

1.31

1.40

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

159

1.44

1.39

1.1

1.0

—

(3006462) Nitrate [Presence] in Urine

272

1230

1.15

1.39

3.2

2.9

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

109

453

1.25

1.39

2.9

2.8

1595.77

1451.84

u/l

0.08

100

405

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.05

1.38

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

389

1.27

1.37

1.1

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

380

1.27

1.36

1.6

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

230

1029

1.16

1.36

1.8

1.7

60702.40

15223.11

u/ml

0.58

142

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

303

1384

1.14

1.35

1.4

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

248

1120

1.15

1.31

2.5

2.8

163.83

133.17

au/ml

0.39

157

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

179

1.39

1.30

1.2

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

2.45

1.30

1.4

2.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1259

6164

1.06

1.27

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

234

1.33

1.25

1.1

—

(3044007) Cell count panel - Peritoneal fluid

192

854

1.17

1.25

2.4

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1257

6161

1.06

1.23

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

164

1.39

1.21

1.5

—

(4211845) Urine protein measurement

296

1362

1.13

1.21

3.1

2.8

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

160

1.40

1.20

1.7

1.8

1.63

0.53

1.21

122

(3010375) cycloSPORINE [Mass/volume] in Blood

226

1342

0.87

1.17

30.2

111.56

113.86

ug/l

0.21

184

1121

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

157

0.63

1.17

1.7

1.3

1.58

1.78

mg/l

0.35

130

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1130

6225

0.94

1.15

1.8

1.6

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.57

1.13

1.0

8099.86

10182.09

ng/l

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

216

1.32

1.12

1.1

16.18

36.07

u/ml

2.15

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

216

1.32

1.12

1.1

25.09

25.65

u/ml

0.02

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

146

642

1.18

1.12

1.1

32.04

30.37

iu/ml

0.12

146

642

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.82

1.12

1.0

0.42

0.14

u/ml

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.77

1.11

1.1

1.0

0.09

0.12

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

464

2202

1.10

1.8

3.80

3.96

mg/l

0.30

435

2124

(3029612) Listeria sp Ab [Titer] in Serum

1.70

1.10

1.4

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

115

1.45

1.09

1.3

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

295

1.27

1.09

2.0

2.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

188

1123

0.87

1.08

2.7

3.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

154

683

1.17

1.08

1.2

1455.00

312.94

titre

—

(40768806) Pleura Pathology biopsy report

587

2818

1.08

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.47

1.04

1.4

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

219

1.31

1.04

1.2

102.46

103.00

ug/l

0.01

136

(3041672) Baker's yeast Ab [Presence] in Serum

174

1.34

1.03

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

335

1.24

1.02

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.48

1.02

1.0

1.1

0.04

0.14

u/ml

0.55

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

273

1268

1.12

1.01

3.4

3.7

8.03

8.57

mg/l

0.64

210

1037

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.49

1.01

1.0

0.08

0.09

u/ml

0.05

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

156

698

1.16

1.00

1.1

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.51

0.98

1.1

0.05

0.04

g/l

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.40

0.97

1.0

13.83

19.08

umol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

261

1213

1.12

0.96

2.9

3.4

1.16

1.23

0.26

261

1213

(3037692) Legionella sp identified in Specimen by Organism specific culture

204

934

1.14

0.96

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

123

543

1.18

0.95

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

356

2028

0.91

0.94

1.4

1.5

34.01

35.04

nmol/l

0.17

320

1901

(3001729) Color of Synovial fluid

191

1.31

0.93

1.6

1.7

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.66

0.92

2.0

2.1

32.36

26.70

0.60

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

151

1.34

0.91

1.0

1.3

—

438.57

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

274

1578

0.90

0.91

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

262

1.25

0.89

1.1

1.2

17.89

17.33

g/l

0.19

247

(3017461) Flecainide [Moles/volume] in Serum or Plasma

143

1.34

0.88

1.4

1.8

0.80

0.70

umol/l

0.41

110

(3026692) Albumin [Mass/volume] in Peritoneal fluid

162

736

1.14

0.88

1.5

1.3

12.67

13.82

g/l

0.80

120

558

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

334

1584

1.10

0.87

1.4

5.86

5.52

mmol/l

3.96

312

1512

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10561

55676

0.98

0.85

3.1

0.67

0.80

ug/l

29.16

6875

34959

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

0.65

0.85

1.2

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.83

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.83

0.0

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

599

0.85

0.83

1.4

22.84

22.11

0.09

491

(3042951) Complement C1q Ab [Units/volume] in Serum

127

1.35

0.82

1.2

1.4

13.02

23.27

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

210

1215

0.90

0.80

1.7

1.6

3126.86

3493.93

titre

0.31

203

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.65

0.79

1.1

—

(3043614) Bacteria identified in Aspirate by Culture

2.36

0.79

1.2

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.80

0.79

1.1

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

490

2375

1.07

0.78

1.2

1.3

80.62

81.60

0.10

161

(3019174) dRVVT (LA screen)

253

1.23

0.78

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.73

0.77

1.0

1.1

3167.33

2846.44

titre

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

186

863

1.12

0.76

2.3

1.8

12134.35

15564.31

e6/l

0.27

437

(3007147) Virus identified in Stool by Electron microscopy

2.17

0.75

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.38

0.74

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

553

2699

1.07

0.73

1.3

6.45

6.24

mmol/l

0.84

512

2530

(3041184) Isoniazid [Presence] in Urine

1.61

0.72

3.4

2.4

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

256

1.22

0.71

1.7

1.6

—

(3027874) Urate [Moles/volume] in Urine

1.36

0.71

1.1

2.06

7.55

mmol/l

0.47

(3039744) RNA polymerase III Ab [Units/volume] in Serum

233

1.23

0.70

1.1

1.0

6.22

4.00

u/ml

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

122

1.32

0.70

10.7

9.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

222

1047

1.10

0.70

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

187

1.25

0.68

1.5

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

346

0.83

0.68

1.4

—

(3020650) Glucose [Presence] in Urine

218

1030

1.10

0.67

1.8

1.4

0.03

0.04

estimate

0.21

218

1030

(3034426) Prothrombin time (PT)

198

931

1.11

0.67

1.2

27.79

28.32

0.83

198

931

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

138

637

1.13

0.65

2.6

432.78

381.56

ug/l

0.05

138

637

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

296

1421

1.08

0.65

1.3

1.2

9.16

9.88

mm/h

0.54

296

1421

(40758292) HTLV I+II Ab panel - Serum

106

628

0.88

0.64

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

162

756

1.11

0.64

1.8

1.9

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.64

0.0

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.41

0.63

1.1

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.62

0.63

1.1

301.56

258.29

u/ml

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

313

1.18

0.63

1.9

1.8

1.79

1.76

mg/l

0.06

264

(3013727) Leukocytes other/Leukocytes in Blood

183

861

1.10

0.62

2.9

3.6

52.34

52.66

0.07

178

828

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

111

1.31

0.62

1.0

0.07

0.15

u/ml

0.41

(3046861) Legionella sp Ag [Presence] in Urine

176

1.24

0.61

1.1

—

(3022670) pH of Venous cord blood

1.47

0.61

1.1

—

(21494434) Karyotype in Bone marrow

490

2402

1.06

0.61

1.1

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

1.83

0.60

1.0

1.2

261.67

75.18

nmol/l

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

324

0.83

0.60

1.1

1.0

1.32

1.18

mom

0.61

324

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

324

0.83

0.60

1.4

75.80

70.66

0.60

265

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

181

0.78

0.60

1.0

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

266

1493

0.93

0.59

41.0

42.5

7.18

7.28

ug/l

0.36

241

1347

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

133

0.74

0.57

1.1

1.0

0.70

0.22

u/ml

0.56

(3010937) Rubella virus Ab [Presence] in Serum

220

0.80

0.57

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.54

0.55

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.51

0.55

1.4

1.0

0.22

1.48

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

126

0.74

0.55

1.1

1.0

0.70

0.40

u/ml

0.27

(3013762) Body weight Measured

1.33

0.54

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.33

0.54

1.1

1.0

5.75

14.57

mg/l

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.35

0.54

1.1

0.23

0.05

g/l

—

(36303858) Crystals [Presence] in Urine

1.57

0.54

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

115

533

1.12

0.54

1.2

27.95

65.22

mg/l

0.54

372

(3023383) Lactate [Moles/volume] in Pleural fluid

147

842

0.91

0.53

1.3

3.66

3.38

mmol/l

0.49

127

781

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

392

1.14

0.53

1.3

1.4

9.14

12.94

0.78

194

(3013336) Amino acids [Identifier] in Serum or Plasma

1.38

0.52

1.7

2.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

707

3835

0.96

0.52

2.5

26.98

27.04

iu/ml

0.00

348

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

286

1.16

0.51

1.0

1.1

24.11

20.14

u/l

0.83

181

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14354

73976

1.01

0.51

4.4

4.3

21.68

22.16

2.85

6281

35634

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.58

0.50

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

189

904

1.09

0.50

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.44

0.49

1.1

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

196

1.19

0.49

1.0

1.1

12.33

21.49

iu/ml

0.47

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

249

1.17

0.48

1.0

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

102

1.27

0.48

1.0

0.11

0.04

u/ml

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

112

1.25

0.46

1.0

1.1

0.05

0.46

mg/l

0.50

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.73

0.45

1.0

1.12

0.85

u/ml

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.41

0.45

1.2

1.1

67.53

63.29

0.37

(3007919) Fasciola sp Ab [Titer] in Serum

1.37

0.45

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

354

1.13

0.44

1.3

5.93

5.80

mmol/l

0.60

354

(43055442) Apixaban [Mass/volume] in Serum or Plasma

413

1.12

0.44

1.5

1.6

128.35

110.48

ug/l

0.78

340

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.48

0.44

1.0

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

0.43

0.0

3.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.43

0.0

1.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.43

0.0

5.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

389

0.88

0.42

1.2

45.58

243.85

u/l

0.96

274

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

190

1.18

0.42

4.6

5.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

352

1736

1.05

0.41

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

218

1209

0.94

0.40

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

215

1.16

0.40

1.1

—

(3045142) Bone marrow Pathology biopsy report

626

3132

1.04

0.40

1.3

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

461

1.10

0.40

1.2

1.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

240

1.15

0.39

1.1

1.2

8.88

9.46

mg/l

0.21

222

(3048879) Bone marrow aspiration report

152

731

1.08

0.39

1.7

1.9

2.00

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

139

1.20

0.38

1.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.30

0.37

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.30

0.37

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.30

0.37

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.30

0.37

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.30

0.37

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.30

0.37

2.0

—

(3018133) Calcium [Moles/volume] in Urine

123

588

1.09

0.37

1.6

2.1

2.67

2.75

mmol/l

0.16

112

539

(3009677) Dengue virus Ab [Presence] in Serum

130

1.20

0.37

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.30

0.37

1.1

1.2

6.49

7.15

kpa

0.91

(3006598) pH of Arterial cord blood

1.30

0.37

1.1

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

1.42

0.36

1.0

1.4

327.17

276.14

nmol/l

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.25

0.36

1.5

1.7

137.27

116.78

ug/l

0.12

(3016135) IgD [Mass/volume] in Serum

1.28

0.35

2.8

1.8

57.36

85.09

mg/l

0.50

(3001893) Eosinophils/Leukocytes in Pleural fluid

160

775

1.07

0.35

1.4

3.01

2.68

0.19

134

652

(3014891) Appearance of Pleural fluid

355

0.89

0.34

1.5

—

(3014178) Parietal cell Ab [Units/volume] in Serum

1.36

0.34

1.0

1.1

48.33

61.04

u/ml

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.36

0.34

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

268

1.12

0.34

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

244

0.87

0.33

2.0

2.5

548.15

346.08

umol/l

0.22

235

(3026470) Cobalt [Mass/volume] in Blood

296

1466

1.05

0.33

2.2

3.27

3.80

ug/l

0.43

272

1361

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.40

0.32

1.0

0.10

0.08

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

205

1.14

0.32

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1291

6566

1.02

0.31

4.9

3.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

216

1.13

0.30

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

136

756

0.93

0.30

6.5

8.0

5.97

5.95

kpa

0.11

122

674

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

148

0.84

0.30

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

128

620

1.07

0.30

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.73

0.30

5.3

3.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

330

1.10

0.30

3.3

3.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

128

621

1.07

0.29

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

1.26

0.28

1.1

1.2

3.97

4.65

kpa

0.20

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

128

622

1.07

0.28

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

121

673

0.93

0.28

6.2

7.9

5.77

5.69

kpa

0.13

121

673

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.21

0.28

1.0

0.03

0.19

u/ml

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

262

0.89

0.28

2.6

4.6

2.39

2.34

mg/l

0.06

225

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

146

0.85

0.27

5.9

12.2

105.13

106.12

g/l

0.16

146

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.26

0.26

1.0

1.1

1154.44

2290.27

titre

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

1.30

0.26

1.0

0.11

3.19

u/ml

—

(37019676) Renin [Units/volume] in Plasma --supine

1.30

0.26

1.0

1.1

18.32

67.54

mu/l

—

(3034614) HLA Ag [Interpretation]

1.24

0.25

1.5

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

180

1.13

0.25

1.1

1.0

0.24

11.70

u/ml

0.52

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

167

0.87

0.25

3.9

3.6

—

(3025577) Chromium [Mass/volume] in Blood

285

1425

1.04

0.24

2.1

2.2

2.39

2.31

ug/l

0.10

239

1201

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

122

0.85

0.24

2.4

3.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

145

714

1.06

0.23

1.9

2.0

22.51

37.92

u/l

1.50

132

657

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.30

0.23

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

155

765

1.05

0.23

1.2

1.3

372.65

203.55

ug/l

0.44

409

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

226

1.10

0.23

1.3

1.23

1.51

ml/s/173m2

0.31

139

(3008536) Aspergillus sp Ab [Presence] in Serum

119

583

1.06

0.23

1.9

2.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

512

2590

1.03

0.23

1.3

546.41

457.94

u/l

0.38

484

2460

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

127

0.86

0.23

2.5

3.4

58980.00

86628.91

u/ml

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.27

0.23

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.27

0.23

1.0

1.1

0.57

0.53

u/ml

0.02

(3051101) Glucose [Moles/volume] in Cord blood

447

1.07

0.22

4.6

5.6

8.76

8.44

mmol/l

0.37

447

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

187

0.89

0.22

1.7

1.4

283.81

308.80

umol/24h

0.43

187

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

9.9

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

153.14

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

470

2377

1.03

0.22

4.4

4.1

65.93

57.93

u/ml

0.18

464

2347

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

499

0.94

0.21

6.1

6.7

10.93

10.68

0.41

499

(3003577) Lead [Moles/volume] in Blood

262

1.09

0.21

1.5

0.31

0.32

umol/l

0.02

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

1.30

0.21

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

326

1641

1.03

0.21

6.3

7.5

100.16

77.82

ug/l

0.13

202

1107

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

391

0.93

0.21

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

449

1.06

0.20

1.6

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.19

0.20

3.5

6.4

5.44

7.75

mg/l

0.35

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.83

0.19

8.5

9.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.16

0.19

1.1

1.3

31.08

33.25

mg/24h

0.24

(3003434) Protein [Mass/volume] in Pleural fluid

744

3794

1.02

0.19

1.4

1.5

33.88

32.74

g/l

1.60

676

3451

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

231

1159

1.04

0.19

1.1

—

(3032641) Amino acids panel - Urine

1.21

0.18

1.0

1.4

—

(3018001) Oat IgE Ab [Units/volume] in Serum

225

1.09

0.18

1.0

0.24

0.83

u/ml

0.65

126

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

189

0.91

0.17

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.22

0.16

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

257

1296

1.03

0.16

1.6

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

389

2070

0.98

0.16

1.2

1.3

15.61

14.33

u/l

0.36

361

1907

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

140

698

1.04

0.16

1.3

41.83

38.56

0.45

101

470

(3001218) Citrate [Mass/time] in 24 hour Urine

1.20

0.16

1.9

1.3

359.33

422.83

mg/24h

0.49

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

392

2085

0.98

0.16

1.2

—

(3003694) ABO and Rh group [Type] in Blood

17245

89869

1.00

0.16

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

418

0.94

0.16

2.1

1.9

—

(3035880) pH of Pleural fluid

266

1422

0.97

0.16

1.2

1.3

7.37

7.41

1.63

179

1024

(40768795) Lymph node Pathology biopsy report

551

2812

1.02

0.15

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

152

1.09

0.14

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

527

0.96

0.14

1.2

1.51

1.63

mmol/l

0.58

334

(3018291) Platelet Ab [Presence] in Serum

1.18

0.13

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.87

0.13

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.15

0.13

3.9

5.6

—

(4038314) Semen analysis, post vasectomy

308

0.94

0.13

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

194

1.07

0.12

1.0

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

235

1.06

0.11

2.3

50.43

62.19

1.29

149

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

236

1255

0.98

0.11

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

129

1.09

0.11

1.3

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

129

1.09

0.11

1.0

1.1

0.00

1.59

u/ml

1.91

129

(3005532) Lymphocytes/Leukocytes in Pleural fluid

174

880

1.03

0.11

1.4

66.03

63.10

0.52

147

722

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

125

0.91

0.11

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

231

1227

0.98

0.10

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

194

0.94

0.10

1.0

1.1

1.73

1.56

u/ml

0.04

132

(4281824) Cell count and differential, peritoneal fluid

553

2910

0.99

0.10

1.1

1.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

186

1.06

0.09

2.5

2.3

17.95

16.32

0.11

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

204

0.94

0.09

2.9

2.4

—

(3000285) Sodium [Moles/volume] in Blood

498

1.03

0.09

1.3

1.2

138.51

138.46

mmol/l

0.04

431

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.12

0.09

1.1

1.0

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.15

0.09

1.0

1.4

0.80

0.63

u/field

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

504

0.97

0.08

1.8

1.7

1.86

3.46

ug/l

1.01

322

(40762814) Titanium [Mass/volume] in Blood

414

0.97

0.08

2.5

3.91

3.63

ug/l

0.13

155

(3032868) Hemoglobin electrophoresis panel in Blood

298

0.96

0.08

1.4

1.6

—

(3049233) Organic acids panel - Urine

0.82

0.08

1.0

1.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

138

702

1.02

0.07

1.4

24.28

20.17

0.90

122

630

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

189

1.04

0.06

4.9

5.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

184

1.04

0.06

2.4

2.1

0.63

0.67

ug/l

0.25

184

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

358

1841

1.01

0.06

1.8

2.1

188.36

883.17

pmol/l

1.14

299

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.07

0.06

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

442

0.98

0.05

1.2

0.63

1.36

mmol/l

1.30

287

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

123

1.06

0.05

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

489

2521

1.01

0.05

1.7

1.8

—

(3007700) Barley IgE Ab [Units/volume] in Serum

160

1.04

0.04

1.1

1.0

1.06

9.34

u/ml

0.44

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

228

1174

1.01

0.03

2.3

2.1

8.44

9.31

mg/l

1.51

184

967

(3023199) Leukocytes [#/volume] in Pleural fluid

647

3378

1.00

0.03

1.4

1.5

5389.48

2712.41

e6/l

0.82

456

2395

(3045788) Cell count panel - Pleural fluid

530

2740

1.01

0.03

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

290

1.02

0.03

1.2

0.17

0.31

u/ml

—

(3022475) Manganese [Moles/volume] in Blood

151

1.03

0.02

1.2

1.3

0.16

umol/l

0.20

151

(46236302) HLA-C [Type] by High resolution typing

119

0.96

0.02

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

140

734

0.99

0.02

1.2

1.3

—

(40765096) Chromosome analysis panel by Banding

156

817

0.99

0.02

1.1

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

0.97

0.01

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.94

0.01

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

332

0.99

0.01

2.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

579

3002

1.00

0.01

1.5

1.4

87935.56

51029.09

e6/l

0.90

326

1725

(3013862) HLA-DP [Type]

118

0.97

0.01

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

147

1.03

0.01

1.1

1.0

0.08

0.07

104

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.06

0.00

1.3

1.2

24.97

30.15

mg/l

0.55

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

168

877

1.00

0.00

1.9

1.7

100.67

128.23

au/ml

0.39

110

(40758358) Immune stain study

102

0.97

0.00

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

959

4987

1.00

0.00

1.3

1.4

3.27

3.79

ug/l

1.46

880

4523

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

122

0.98

0.00

3.5

3.7

—

(3003157) Bacteria [#/volume] in Mother's milk

0.97

0.00

9.4

6.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

129

1.01

0.00

1.1

1.3

0.10

0.07

g/l

0.50

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

160

1.01

0.00

3.8

5.3

—

(40760410) HLA-B [Type] by High resolution

117

0.98

0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

117

0.98

0.00

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

117

0.98

0.00

1.1

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

133

690

1.00

0.00

2.6

2.7

107.84

110.09

ng/l

0.07

412

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

197

1.00

0.00

2.7

2.6

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.04

0.00

7.8

10.0

56.67

46.13

—

(40763590) HLA-DQ beta [Type]

116

0.99

0.00

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

149

1.01

0.00

10.7

105.18

238.11

e6/l

0.97

105

(3012989) Citrate [Moles/time] in 24 hour Urine

0.99

0.00

2.0

1.5

1.68

2.04

mmol/24h

0.93

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.00

0.00

1.1

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.96

-0.00

1.0

3.0

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.94

-0.00

2.7

2.6

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.93

-0.00

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.87

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: SSRI – Selective serotonin reuptake inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Selective serotonin reuptake inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Selective serotonin reuptake inhibitors (SSRI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints